10000000000000000_1	Interferon Describe the drug Interferon its uses effectiveness patient tolerance and side effects.	interferon describ drug interferon use effect patient toler side effect
19960522000000000_1	China Starts Mass Producing Genetic Engineering Drug.	china start mass produc genet engin drug
19960522000000000_2	BEIJING May 22 (Xinhua) China has started to put into mass production a genetic engineering drug which can effectively treat liver diseases.	beij may xinhua china ha start put mass product genet engin drug effect treat liver diseas
19960522000000000_3	Chen Zhangliang the 35 year old vice president of Beijing University declared at a seminar here today that recombinant a 1b interferon was approved for production by the Ministry of Public Health in April this year and has become China s first genetic engineering drug to be put into mass production in the biotechnology section of the country s "863 Hi Tech Plan".	chen zhangliang year old vice presid beij univers declar seminar today recombin b interferon wa approv product ministri public health april thi year ha becom china first genet engin drug put mass product biotechnolog section countri hi tech plan
19960522000000000_4	China listed biotechnology among its top eight fields for scientific and technological development in 1978.	china list biotechnolog among top eight field scientif technolog develop
19960522000000000_5	Biotechnology was listed among the top seven pioneering sciences in March 1986 when the "863" plan was introduced.	biotechnolog wa list among top seven pioneer scienc march plan wa introduc
19960522000000000_6	So far China has put onto the market five genetic engineering drugs and another dozen such drugs are under research.	far china ha put onto market five genet engin drug anoth dozen drug research
19960522000000000_7	Interferon is a protein isolated from human cells and internationally acknowledged as efficacious for the treatment of liver diseases experts said.	interferon protein isol human cell intern acknowledg efficaci treatment liver diseas expert said
19960522000000000_8	In the early 1980s China s first interferon research lab was established under the directorship of Hou Yunde a member of the Chinese Academy of Preventive Medicine and a leading scientist in the "863" plan.	earli china first interferon research lab wa establish directorship hou yund member chines academi prevent medicin lead scientist plan
19960522000000000_9	He discovered for the first time that the white blood cells of Chinese people when attacked by viruses will produce "a 1" type instead of "a 2" type interferons.	discov first time white blood cell chines peopl attack virus produc type instead type interferon
19960522000000000_10	He subsequently succeeded in developing recombinant a 1b interferon the first interferon expressed by a gene isolated from healthy Chinese leukocyte cells.	subsequ succeed develop recombin b interferon first interferon express gene isol healthi chines leukocyt cell
19960522000000000_11	To put the interferon into mass production the Shenzhen Kexing Bioproducts Co.	put interferon mass product shenzhen kex bioproduct co
19960522000000000_12	Ltd China s largest genetic engineering medicine production base was set up in 1993 under the State Science and Technology Commission.	ltd china largest genet engin medicin product base wa set state scienc technolog commiss
19961215000000000_1	NEW DELHI December 15 (Xinhua) Two new drugs that e Press Trust of India while attending a symposium on transfusion associated hepatitis here.	new delhi decemb xinhua two new drug e press trust india attend symposium transfus associ hepat
19961215000000000_2	Interferon based therapy however works only in one third of the cases while about 70 percent of the patients do not benefit from it.	interferon base therapi howev work onli one third case percent patient benefit
19961215000000000_3	The two drugs lamivudine and famciclovir can be given orally and are well tolerated Thomas said.	two drug lamivudin famciclovir given oral well toler thoma said
19961215000000000_4	They are expected to have fewer side effects compared to interferons that cause fever and lethargy.	expect fewer side effect compar interferon caus fever lethargi
19961215000000000_5	The drugs have completed Phase I and Phase II trials for safety and efficacy and are currently undergoing Phase III multi centric trials in the United States Europe and Southeast Asia.	drug complet phase phase ii trial safeti efficaci current undergo phase iii multi centric trial unit state europ southeast asia
19961215000000000_6	The trials being conducted by a team of 20 investigators commenced a year ago and their results are expected to be out in 1997.	trial conduct team investig commenc year ago result expect
19961215000000000_7	Experts are also working on an improved modified vaccine for hepatitis B Thomas said.	expert also work improv modifi vaccin hepat b thoma said
19980131000000000_1	Hepatitis C Becomes Major Worldwide Health Problem.	hepat c becom major worldwid health problem
19980131000000000_2	LONDON January 30 (Xinhua) Hepatitis C is now being recognized as a major public health problem worldwide an American expert said today in The Lancet medical journal.	london januari xinhua hepat c recogn jor public health problem worldwid american expert said today lancet medic journal
19980131000000000_3	In most developed countries 1e to 2 percent of the population is infected with the virus wrote Dr Adrian Di Bisceglie of Saint Louis University School of Medicine in Missouri the United States.	develop countri e percent popul infect viru wrote dr adrian di biscegli saint loui univers school medicin missouri unit state
19980131000000000_4	Infection rates are higher in some parts of eastern Europe and in Africa and he said.	infect rate higher part eastern europ africa said
19980131000000000_5	Liver disease caused by hepatitis C is now the major reason for liver transplantation in adults in most countries.	liver diseas caus hepat c jor reason liver transplant adult countri
19980131000000000_6	In the United States alone hepatitis C now causes 8 000 to 10 000 deaths a year.	unit state alon hepat c caus death year
19980131000000000_7	Hepatitis C is predominantly a blood borne disease.	hepat c predominantli blood born diseas
19980131000000000_8	Eighty five percent of people infected with the virus in most cases will develop a chronic hepatitis and of these as many as 20 percent eventually develop cirrhosis.	eighti five percent peopl infect viru case develop chronic hepat mani percent eventu develop cirrhosi
19980131000000000_9	Di Bisceglie said the antiviral drug interferon had reduced symptoms in up to 20 percent of patients with hepatitis C who were treated for six months.	di biscegli said antivir drug interferon reduc symptom percent patient hepat c treat six month
19980131000000000_10	In some cases the virus disappears from the blood and the inflammation of the liver is reduced.	case viru disappear blood inflamm liver reduc
19980131000000000_11	Some studies also indicate that longer therapy lasting a year to 18 months may achieve a sustained response in as many as 30 percent of treated patients.	studi also indic longer therapi last year month may achiev sustain respons mani percent treat patient
19980603203500000_1	NEW TREATMENT FOR CHRONIC HEPATITIS C IS APPROVED.	new treatment chronic hepat c approv
19980603203500000_2	The Food and Drug Administration on Wednesday approved a powerful combination of two antiviral drugs to treat chronic hepatitis C a liver infection that can lead to cirrhosis liver cancer and liver failure.	food drug administr wednesday approv power combin two antivir drug treat chronic hepat c liver infect lead cirrhosi liver cancer liver failur
19980603203500000_3	Four million Americans are estimated to have chronic hepatitis C and 10 000 die from it each year.	four million american estim chronic hepat c die year
19980603203500000_4	The newly approved treatment known as Rebetron works far better than sole standard treatment.	newli approv treatment known rebetron work far better sole standard treatment
19980603203500000_5	But it is expensive it poses serious side effects and works in only about half the patients who take it.	expens pose seriou side effect work onli half patient take
19980603203500000_6	Although it can eradicate signs of infection it cannot be called a cure.	although erad sign infect cannot call cure
19980603203500000_7	And doctors say that not everyone with hepatitis C needs it.	doctor say everyon hepat c need
19980603203500000_8	The treatment consists of a six month course of interferon injections and ribavirin capsules.	treatment consist six month cours interferon inject ribavirin capsul
19980603203500000_9	The full course of therapy will cost 6 400 to 8 600 depending on how high a dose a patient needs.	full cours therapi cost depend high dose patient need
19980603203500000_10	has been approved for use only in people who relapse after the standard treatment for hepatitis C which is a course of interferon injections.	ha approv use onli peopl relaps standard treatment hepat c cours interferon inject
19980603203500000_11	That therapy eliminates the disease in only 10 percent to 20 percent of patients.	therapi elimin diseas onli percent percent patient
19980603203500000_12	The remaining 30 percent to 40 percent respond to interferon and then relapse and those are the patients for whom Rebetron has been approved.	remain percent percent respond interferon relaps patient rebetron ha approv
19980603203500000_13	Tested in such a group Rebetron reduced the virus to undetectable levels in 45 percent an effect that persisted when the patients were tested again six months after treatment ended.	test group rebetron reduc viru undetect level percent effect persist patient test six month treatment end
19980603203500000_14	In patients given interferon alone only 5 percent had undetectable levels.	patient given interferon alon onli percent undetect level
19980603203500000_15	Leonard Seeff a senior scientist for hepatitis C research at the National Institute of Diabetes and Digestive and Kidney Diseases who was not involved in the study said those results meant there was a good chance that the effects would last.	leonard seeff senior scientist hepat c research nation institut diabet digest kidney diseas wa involv studi said result meant wa good chanc effect would last
19980603203500000_16	In studies of patients who responded to interferon alone he said those who were free of the virus at six months remained so at six years.	studi patient respond interferon alon said free viru six month remain six year
19980603203500000_17	But I m not sure we won t find people with recurring disease as we go further out Seeff said.	sure find peopl recur diseas go seeff said
19980603203500000_18	We need a much longer time to follow all these people.	need much longer time follow peopl
19980603203500000_19	Even though Rebetron has been approved only for patients who have relapsed after trying interferon doctors will be free to prescribe it as they see fit.	even though rebetron ha approv onli patient relaps tri interferon doctor free prescrib see fit
19980603203500000_20	Jay Hoofnagle director of the division of digestive diseases and nutrition at the national institute said they expected that many doctors would prescribe it for all hepatitis C patients including those who have not taken interferon or who did not respond to it.	jay hoof nagl director divis digest diseas nutrit nation institut said expect mani doctor would prescrib hepat c patient includ taken interferon respond
19980603203500000_21	Hoofnagle said data had been presented at medical meetings showing that when the combination was given for one year to people who had never been treated before the relapse rate was only 20 percent.	hoof nagl said data present medic meet show combin wa given one year peopl never treat befor relaps rate wa onli percent
19980603203500000_22	Given the poor response rate with interferon alone he said it seems reasonable to go straight to the combination.	given poor respons rate interferon alon said seem reason go straight combin
19980603203500000_23	While interferon alone is associated with flulike side effects ribavirin can cause severe anemia that comes on suddenly Hoofnagle said and in people with cardiovascular disease that can touch off a heart attack or stroke.	interferon alon associ flulik side effect ribavirin caus sever anemia come suddenli hoof nagl said peopl cardiovascular diseas touch heart attack stroke
19980603203500000_24	It can also cause birth defects so women must avoid pregnancy while they take it and for six months after.	also caus birth defect women must avoid pregnanc take six month
19980603203500000_25	In addition the interferon component of the treatment causes flulike symptoms.	addit interferon compon treatment caus flulik symptom
19980603203500000_26	Because of the risks of treatment and its partial success rate Hoofnagle said doctors have tried to determine which patients truly need it rather than just giving the drugs to everyone with hepatitis C.	becaus risk treatment partial success rate hoof nagl said doctor tri determin patient truli need rather give drug everyon hepat c
19980603203500000_27	Only 20 percent to 30 percent of people with chronic infections develop cirrhosis liver failure or cancer.	onli percent percent peopl chronic infect develop cirrhosi liver failur cancer
19980603203500000_28	It is impossible to predict just which ones will become severely ill but medical authorities now recommend treatment only for patients who have detectable viral levels and abnormal results on tests of liver enzymes.	imposs predict one becom sever ill medic author recommend treatment onli patient detect viral level abnorm result test liver enzym
19980603203500000_29	Others can be monitored and treated later if the disease seems to be progressing.	monitor treat later diseas seem progress
19980603203500000_30	If it s mild I say let s follow it carefully and wait it out until we have a little bit better therapy Hoofnagle said.	mild say let follow care fulli wait littl bit better therapi hoof nagl said
19980603203500000_31	Some people don t want to be treated at all but others are so anxious that they don t care what you tell them and they just want to be treated.	peopl want treat anxiou care tell want treat
19980708131700000_1	AIDS drug found useful in hepatitis C.	aid drug found use ful hepat c
19980708131700000_2	BOSTON (AP) A standard AIDS drug appears to slow liver damage caused by hepatitis B.	boston ap standard aid drug appear slow liver damag caus hepat b
19980820164000000_1	Young people who reveled in the hedonism of the 1960s and 70s are discovering that the legacy of those years is a devastating and sometimes fatal disease now reaching epidemic proportions.	young peopl revel hedon discov legaci year devast sometim fatal diseas reach epidem proport
19980820164000000_2	Little did they know that intravenous drug use tattoos and body piercing would be an invitation to a slow growing virus that eventually would become the recently identified hepatitis C.	littl know intraven drug use tattoo bodi pierc would invit slow grow viru eventu would becom recent identifi hepat c
19980820164000000_3	Like other forms of hepatitis the C variety inflames the liver causing debilitating symptoms or even more frightening virtually no symptoms until the disease is on the eve of destruction.	like form hepat c varieti inflam liver caus debilit symptom even frighten virtual symptom diseas eve destruct
19980820164000000_4	The risk of contracting hepatitis C continues today.	risk contract hepat c continu today
19980820164000000_5	Foolhardy people still pierce tattoo and inject themselves with unsterile needles.	fool hardi peopl still pierc tattoo inject themselv unsteril needl
19980820164000000_6	Unsafe promiscuous sex can put partners in danger.	unsaf promiscu sex put partner danger
19980820164000000_7	Health care workers who suffer accidental needle sticks must be on guard.	health care worker suffer accident needl stick must guard
19980820164000000_8	In the future these people too could begin to feel the effects of the insidious illness.	futur peopl could begin feel effect insidi ill
19980820164000000_9	But it s patients who received blood transfusions before 1992 before testing of the blood supply was refined who are the target of an intense public education campaign spearheaded by the office of the U.	patient receiv blood transfus befor befor test blood suppli wa refin target intens public educ campaign spearhead offic u
19980820164000000_10	Satcher s office has urged organizations such as the American Red Cross hospitals and blood banks to notify pre 1992 blood recipients and recommend they be tested for hepatitis C.	satcher offic ha urg organ american red cross hospit blood bank notifi pre blood recipi recommend test hepat c
19980820164000000_11	Identifying and contacting that population will be a daunting but worthwhile task doctors say.	identifi contact popul daunt worth task doctor say
19980820164000000_12	Though critics have questioned the cost effectiveness of alerting people to a disease that can be treated in less than half of all cases health care advocates insist patients have a right to know their health status and that withholding information is disgraceful.	though critic question cost effect alert peopl diseas treat less half case health care advoc insist patient right know health statu withhold inform disgrac
19980820164000000_13	Michael Altman a Phoenix gastroenterologist president of the Arizona chapter of the American Liver Foundation.	michael altman phoenix gastroenterologist presid arizona chapter american liver foundat
19980820164000000_14	Although conceding that better treatments are needed he says he can offer patients hope.	although conced better treatment need say offer patient hope
19980820164000000_15	Only about 5 percent of patients refuse medication he says.	onli percent patient refus medic say
19980820164000000_16	Even those who cannot be cured must be informed on how to manage their disease and how to avoid transmitting it.	even cannot cure must inform manag diseas avoid transmit
19980820164000000_17	They should drink no alcohol be scrupulous about protecting others from infection and maintain good nutrition.	drink al cohol scrupul protect infect maintain good nutrit
19980820164000000_18	How long hepatitis C has been around is anybody s guess.	long hepat c ha around ani bodi guess
19980820164000000_19	It may have its origins in World War II where unsterile battlefield blood transfusions could have spread the virus.	may origin world war ii unsteril battlefield blood transfus could spread viru
19980820164000000_20	First called non A non B hepatitis because its specific virus couldn t be differentiated from other strains it wasn t identified until 1975.	first call non non b hepat becaus specif viru differenti strain identifi
19980820164000000_21	Unlike hepatitis A (transmitted through unsanitary food preparation) and hepatitis B (spread through blood and sexual contact) for which there are vaccines and effective cures the C strain becomes chronic in 85 percent of cases.	unlik hepat transmit unsanitari food prepar hepat b spread blood sexual contact vaccin effect cure c strain becom chronic percent case
19980820164000000_22	It is the leading cause of cirrhosis which scars the liver and inhibits its function.	lead caus cirrhosi scar liver inhibit function
19980820164000000_23	Estimates put the number of infected Americans at 4 million.	estim put number infect american million
19980820164000000_24	Cases of HIV the virus that causes AIDS number only 1 million.	case hiv viru caus aid number onli million
19980820164000000_25	Although deaths from the human immunodeficiency virus are declining fatal cases of hepatitis C are rising expecting to triple in the next 10 years.	although death human immunodefici viru declin fatal case hepat c rise expect tripl next year
19980820164000000_26	Yet HIV has enjoyed much more media and medical attention.	yet hiv ha enjoy much media medic attent
19980820164000000_27	Doctors who work with hepatitis C patients are dismayed by such inequities.	doctor work hepat c patient dismay inequ
19980820164000000_28	You see the furor raised over HIV says Altman the Phoenix gastroenterologist.	see furor rais hiv say altman phoenix gastroenterologist
19980820164000000_29	Consequently three fourths of all victims of hepatitis C are unaware they carry the disease.	consequ three fourth victim hepat c unawar carri diseas
19980820164000000_30	Yet when hepatitis C reaches its end stage it becomes the leading reason for liver transplants.	yet hepat c reach end stage becom lead reason liver transplant
19980820164000000_31	More than 4 000 transplants are performed each year and 10 000 names are on the waiting list.	transplant perform year name wait list
19980820164000000_32	Although diseased kidneys can be assisted by dialysis no machine can perform the functions of the liver.	although diseas kidney assist dialysi machin perform function liver
19980820164000000_33	5 pounds the organ has a lot of reserve says Dr.	pound organ ha lot reserv say dr
19980820164000000_34	David Leibowitz gastroenterologist and chair of the department of medicine at Good Samaritan Regional Medical Center.	david leibowitz gastroenterologist chair depart medicin good samaritan region medic center
19980820164000000_35	Unfortunately the liver s large capacity allows it to quietly harbor disease for many years without signaling its deterioration.	unfortun liver larg capac allow quietli harbor diseas mani year without signal deterior
19980820164000000_36	When the silence finally is broken the patient may experience fatigue malaise flulike symptoms weakness jaundice.	silenc final broken patient may experi fatigu malais flulik symptom weak jaundic
19980820164000000_37	More serious symptoms indicating advanced disease include fluid retention in the ankles and abdomen confusion increased risk of bleeding intestinal bleeding.	seriou symptom indic advanc diseas includ fluid retent ankl abdomen confus increas risk bleed intestin bleed
19980820164000000_38	Until a routine blood test picks up elevated liver enzymes problems may go undetected.	routin blood test pick elev liver enzym problem may go undetect
19980820164000000_39	Only a specific blood test will identify hepatitis C.	onli specif blood test identifi hepat c
19980820164000000_40	Our goal is to catch hepatitis C early says Dr.	goal catch hepat c earli say dr
19980820164000000_41	David Douglas a liver specialist at Mayo Clinic Scottsdale.	david dougla liver specialist mayo clinic scottsdal
19980820164000000_42	We hope to catch people before they develop cirrhosis.	hope catch peopl befor develop cirrhosi
19980820164000000_43	Douglas is director of the Mayo liver clinic and medical director of the liver transplant program which is just getting under way.	dougla director mayo liver clinic medic director liver transplant program get way
19980820164000000_44	Mayo is conducting several research protocols on hundreds of hepatitis C patients.	mayo conduct sever research protocol hundr hepat c patient
19980820164000000_45	Although doctors hesitate to call treatments for hepatitis C cures scattered bits of virus may remain says Leibowitz of the Good Samaritan Regional Medical Center medication does offer some hope.	although doctor hesit call treatment hepat c cure scatter bit viru may remain say leibowitz good samaritan region medic center medic doe offer hope
19980820164000000_46	Currently the drug of choice is interferon which produces remission or suppression of the virus in about 20 percent of cases.	current drug choic interferon produc remiss suppress viru percent case
19980820164000000_47	That means liver enzymes appear normal and the virus cannot be detected.	mean liver enzym appear normal viru cannot detect
19980820164000000_48	Interferon is delivered as self administered injections three times a week for 12 to 18 months.	interferon deliv self administ inject three time week month
19980820164000000_49	Some experience serious physical and emotional side effects including depression.	experi seriou physic emot side effect includ depress
19980820164000000_50	Food and Drug Administration approved use of another drug ribavirin which in combination with interferon boosts recovery rates to 40 percent.	food drug administr approv use anoth drug ribavirin combin interferon boost recoveri rate percent
19980820164000000_51	That s significant says Douglas of Mayo Clinic Scottsdale.	signific say dougla mayo clinic scottsdal
19980820164000000_52	Such combinations of drugs called cocktails are proving to be sound methods of treatment for diseases such as hepatitis C and AIDS.	combin drug call cocktail prove sound method treatment diseas hepat c aid
19980820164000000_53	Douglas predicts that more drugs including anti viral agents will be developed and used to battle hepatitis C in the next three to five years.	dougla predict drug includ anti viral agent develop use battl hepat c next three five year
19980820164000000_54	A research laboratory in California also is working on a vaccine says Good Samaritan s Leibowitz that could be used one day to immunize all newborns in the same way infants are currently vaccinated against hepatitis B.	research laboratori california also work vaccin say good samaritan leibowitz could use one day immun new born way infant current vaccin hepat b
19980820164000000_55	So called universal vaccines are the way to go he says.	call univers vaccin way go say
19980820164000000_56	Education is the key to managing hepatitis C now Douglas says.	educ key manag hepat c dougla say
19980820164000000_57	We ve been trying to raise public awareness of hepatitis C he says.	tri rais public awar hepat c say
19980820164000000_58	The American Liver Foundation is committed to supporting research and informing the public about liver diseases.	american liver foundat commit support research inform public liver diseas
19980820164000000_59	The foundation lobbies Congress for funding and works with the National Institutes of Health.	foundat lobbi congress fund work nation institut health
19980820164000000_60	In the Valley the Arizona chapter of the Liver Foundation sponsors monthly support groups for patients hosts seminars for patients and primary care physicians and conducts programs in schools that alert children to the dangers of drug and alcohol abuse.	valley arizona chapter liver foundat sponsor monthli support group patient host seminar patient primari care physician conduct program school alert children danger drug al cohol abus
19980820164000000_61	Altman who also participates in research studies is optimistic about the treatment of hepatitis C.	altman also particip research studi optimist treatment hepat c
19980820164000000_62	I tell my patients to call me every six months.	tell patient call everi six month
19980820164000000_63	We re all frustrated by having a 20 percent cure rate (with interferon alone) but it s the best we ve got right now.	frustrat percent cure rate interferon alon best got right
19980820164100000_1	Once an avid cyclist who rode 40 miles a day to her job running a California bed and breakfast Ward no longer could get out of bed.	onc avid cyclist rode mile day job run california bed break fast ward longer could get bed
19980820164100000_2	Debilitating fatigue forced her to abandon the B AMP.	debilit fatigu forc abandon b amp
19980820164100000_3	For three to four months she would feel well.	three four month would feel well
19980820164100000_4	Then the fatigue would return with a vengeance knocking her flat for two weeks to two months.	fatigu would return vengeanc knock flat two week two month
19980820164100000_5	She suffered chronic back problems gastrointestinal disorders recurrent yeast infections fever and night sweats excruciating muscle pain.	suffer chronic back problem gastrointestin disord recurr yeast infect fever night sweat excruci muscl pain
19980820164100000_6	I thought I was insane says Ward 41 who now lives in Phoenix.	thought wa insan say ward live phoenix
19980820164100000_7	You lay in bed and cry because your entire body hurts.	lay bed cri becaus entir bodi hurt
19980820164100000_8	She was treated for countless diseases but continued to languish.	wa treat countless diseas continu languish
19980820164100000_9	For almost five months in 1994 she couldn t keep food down and lived on liquid supplements sipped a few tablespoons every hour.	almost five month keep food live liquid supplement sip tablespoon everi hour
19980820164100000_10	When doctors treated her for reflux disease she improved some and subsisted on a liquid diet.	doctor treat flux diseas improv subsist liquid diet
19980820164100000_11	The next year a holistic doctor told her she had liver disease.	next year holist doctor told liver diseas
19980820164100000_12	hepatitis C once known by the vague label non A non B hepatitis.	hepat c onc known vagu label non non b hepat
19980820164100000_13	For perhaps 20 years she would learn the hepatitis C virus had been preying on her body causing chronic inflammation of her liver an organ whose job is to detoxify and discard products produced in the body.	perhap year would learn hepat c viru prey bodi caus chronic inflamm liver organ whose job detoxifi discard product produc bodi
19980820164100000_14	It also manufactures proteins clotting factors and hormones.	also manufactur protein clot factor hormon
19980820164100000_15	Hepatitis C which experts say is reaching epidemic proportions has become the leading reason for liver transplants.	hepat c expert say reach epidem proport ha becom lead reason liver transplant
19980820164100000_16	Such celebrities as daredevil Evel Knievel and singer Naomi Judd a former nurse have hepatitis C.	celebr daredevil evel knievel singer naomi judd former nurs hepat c
19980820164100000_17	Rock singer David Crosby underwent a liver transplant in 1994 after fighting alcoholism and hepatitis C.	rock singer david crosbi underw liver transplant fight al cohol hepat c
19980820164100000_18	Hepatitis C most often is passed from person to person by way of blood transfusions intravenous drug use unsterile needles used in body piercing or tattooing accidental needle sticks by health care workers and to a lesser extent unsafe promiscuous sex.	hepat c often pass person person way blood transfus intraven drug use unsteril needl use bodi pierc tattoo accident needl stick health care worker lesser extent unsaf promiscu sex
19980820164100000_19	Ward says that in her younger days she dabbled in marijuana and cocaine.	ward say younger day dabbl marijuana cocain
19980820164100000_20	Snorting cocaine can rupture tiny blood vessels in the nostrils and allow tainted blood to be passed when coke straws are shared.	snort cocain ruptur tini blood vessel nostril allow taint blood pass coke straw share
19980820164100000_21	Ward also has discovered that several former friends who were patients of her dentist in California have come down with hepatitis C.	ward also ha discov sever former friend patient dentist california come hepat c
19980820164100000_22	She may never know the cause of her disease but her concern now is to keep it at bay and ward off the worst of liver ailments cirrhosis and cancer.	may never know caus diseas concern keep bay ward worst liver ailment cirrhosi cancer
19980820164100000_23	Cirrhosis produces scarring of the liver tissue and prevents it from performing its detoxification duties.	cirrhosi produc scar liver tissu prevent perform detoxif duti
19980820164100000_24	Ward has just finished a year of treatment on the only drug that works on hepatitis C.	ward ha finish year treatment onli drug work hepat c
19980820164100000_25	Used alone interferon results in remission in about 20 percent of cases.	use alon interferon result remiss percent case
19980820164100000_26	Participating in an experimental program at Mayo Clinic Scottsdale she has been giving herself injections of interferon three times a week.	particip experiment program mayo clinic scottsdal ha give inject interferon three time week
19980820164100000_27	She also has been taking a pill that may be a drug called ribavirin which can boost the effectiveness of interferon and double its cure rate.	also ha take pill may drug call ribavirin boost effect interferon doubl cure rate
19980820164100000_28	Because she is in a double blind study she may have been taking a placebo.	becaus doubl blind studi may take placebo
19980820164100000_29	For some people interferon treat ment can be nearly as devastating as the disease it s meant to cure.	peopl interferon treat ment nearli devast diseas meant cure
19980820164100000_30	You feel like you have the flu all the time says Ward who has battled lethargy clogged saliva glands chronic yeast infections urinary tract infections and depression all because of the treatment.	feel like flu time say ward ha battl lethargi clog saliva gland chronic yeast infect urinari tract infect depress becaus treatment
19980820164100000_31	If the interferon ultimately proves ineffective however she would begin a second course.	interferon ultim prove ineffect howev would begin second cours
19980820164100000_32	Ward lives with her elderly mother who is blind and has cancer and depends on public assistance.	ward live elderli mother blind ha cancer depend public assist
19980820164100000_33	She is hoping to find a job and obtain Social Security disability payments.	hope find job obtain social secur disabl payment
19980820164100000_34	To bolster her emotional state she attends a support group for hepatitis C patients but says that can be troubling.	bolster emot state attend support group hepat c patient say troubl
19980820164100000_35	Although she receives solace from group members dealing in turn with their woes is saddening.	although receiv solac group member deal turn woe sadden
19980820164100000_36	I would give up anything to be able to speak one on one with a counselor once a week she says.	would give anyth abl speak one one counselor onc week say
19980820164100000_37	Though her condition has improved Ward fears a relapse.	though condit ha improv ward fear relaps
19980820164100000_38	Since I m in remission I feel I m going to get better she says.	sinc remiss feel go get better say
19980820164100000_39	At one time Ward felt guilty about her disease.	one time ward felt guilti diseas
19980820164100000_40	I thought I was a horrible person because I contracted hepatitis C she says.	thought wa horribl person becaus contract hepat c say
19980820164100000_41	Family members have been emotionally and financially supportive but some relatives refuse to visit her believing they will become infected.	famili member emot financi support rel refus visit believ becom infect
19980820164100000_42	Now noting how many other people have hepatitis C an estimated 4 million representing all walks of life she no longer feels shame which has given her the courage to counsel others.	note mani peopl hepat c estim million repres walk life longer feel shame ha given courag counsel
19980820164100000_43	She even advocates for patients seeking transplants though she has decided that she would not undergo transplant surgery herself if her condition deteriorated.	even advoc patient seek transplant though ha decid would undergo transplant surgeri condit deterior
19980820164100000_44	This is the way I came into the world and this is the way I ll leave this world.	thi way came world thi way leav thi world
19981118191100000_1	Two drugs better than one for treating chronic hepatitis.	two drug better one treat chronic hepat
19981118191100000_2	A combination of two virus fighting drugs has proved considerably more effective against chronic hepatitis C infections than the standard single medicine.	combin two viru fight drug ha prove consider effect chronic hepat c infect standard singl medicin
19981119131000000_1	STUDIES COULD ADVANCE HEPATITIS C TREATMENT STUDY SHOWS PROZAC FIGHTS PANIC DISORDER MAJOR LUNG SURGERY IS SMALL OPERATION.	studi could advanc hepat c treatment studi show prozac fight panic disord major lung surgeri small oper
19981119131000000_2	Until now there has been no truly effective treatment for hepatitis C a blood borne virus that is spread in the same ways as AIDS and that is believed to infect about 4 million Americans.	ha truli effect treatment hepat c blood born viru spread way aid believ infect million american
19981119131000000_3	A drug called interferon helps in 40 percent of cases but the benefits are short lived.	drug call interferon help percent case benefit short live
19981119131000000_4	Only 10 to 15 percent of patients remain in remission six months after treatment is stopped.	onli percent patient remain remiss six month treatment stop
19981119131000000_5	But two studies published in the current New England Journal of Medicine offer new hope.	two studi publish current new england journal medicin offer new hope
19981119131000000_6	One led by researchers at the Scripps Clinic and Research Foundation in La Jolla Calif.	one led research scripp clinic research foundat la jolla calif
19981119131000000_7	found that six months after treatment a combination of interferon and a drug called ribavirin was 31 to 38 percent effective among patients being treated for the first time.	found six month treatment combin interferon drug call ribavirin wa percent effect among patient treat first time
19981119131000000_8	That s 3 to 5 times the response rate for people getting interferon alone.	time respons rate peopl get interferon alon
19981119131000000_9	The other study led by researchers at the University of Florida College of Medicine in Gainesville found that six months after treatment the same combination was 49 percent effective in patients who had relapsed after previous treatment.	studi led research univers florida colleg medicin gain vill found six month treatment combin wa percent effect patient relaps previou treatment
19981119131000000_10	This is 10 times higher than treatment with interferon alone.	thi time higher treatment interferon alon
19981119131000000_11	Together the studies represent an important advance says Dr.	togeth studi repres import advanc say dr
19981119131000000_12	Jake Liang chief of the liver diseases section at the National Institute of Diabetes Digestive and Kidney Diseases part of the National Institutes of Health.	jake liang chief liver diseas section nation institut diabet digest kidney diseas part nation institut health
19981119131000000_13	In the California study there was little difference in outcome whether people were treated for six months or 12.	california studi wa littl differ come whether peopl treat six month
19981119131000000_14	But the studies are a big step forward Liang said in a telephone interview.	studi big step forward liang said telephon interview
19981119131000000_15	Study shows Prozac fights panic disorder LR.	studi show prozac fight panic disord lr
19981119131000000_16	Prozac like the antidepressants Zoloft and Paxil has now been shown to work against panic disorder a debilitating illness that affects 3 million Americans.	prozac like antidepress zoloft paxil ha shown work panic disord debilit ill affect million american
19981119131000000_17	David Michelson of Eli Lilly the maker of Prozac the popular antidepressant proved safe and effective in reducing panic attacks and symptoms of phobia anxiety and depression in people with panic disorder a syndrome in which a person suffers repeated attacks of panic.	david michelson eli lilli maker prozac popular antidepress prove safe effect reduc panic attack symptom phobia anxieti depress peopl panic disord syndrom person suffer repeat attack panic
19981119131000000_18	The study is in this month s American Journal of Psychiatry.	studi thi month american journal psychiatri
19981119131000000_19	In a separate study published in the current Journal of the American Medical Association Brown University researchers showed that Zoloft already used for acute depression is also effective as an ongoing treatment for chronic depression.	separ studi publish current journal american medic associ brown univers research show zoloft al readi use acut depress also effect ongo treatment chronic depress
19981119131000000_20	Major lung surgery is small operation LR.	major lung surgeri small oper lr
19981119131000000_21	Minimally invasive surgery in which doctors operate through one or more small incisions often aided by tiny TV cameras in fiber optic cables is clearly an idea whose time has come.	minim invas surgeri doctor oper one small incis often aid tini tv camera fiber optic cabl clearli idea whose time ha come
19981119131000000_22	who describes his technique in this month s issue of Chest a journal of the American College of Chest Physicians.	describ hi techniqu thi month issu chest journal american colleg chest physician
19981119131000000_23	Traditionally surgeons have used one long incision from the shoulder blade under the arm around to the front to remove a cancerous lung.	tradit surgeon use one long incis shoulder blade arm around front remov cancer lung
19981119131000000_24	In the last five years they ve also used minimally invasive surgery which involves four or five small incisions between the ribs for viewing plus a 4 inch incision under the arm through which the lung is removed.	last five year also use minim invas surgeri involv four five small incis rib view plu inch incis arm lung remov
19981119131000000_25	Now Tovaro says he can remove a lung using only one small 3 inch incision on the patient s side.	tovaro say remov lung use onli one small inch incis patient side
19981119131000000_26	In the five patients reported on he has also done four others Tovar occasionally uses a miniature TV camera inserted through the same incision to see ligaments that he needs to cut.	five patient report ha also done four tovar occasion use miniatur tv camera insert incis see ligament need cut
19981119131000000_27	With standard minimally invasive surgery patients stay in the hospital five to seven days.	standard minim invas surgeri patient stay hospit five seven day
19981119131000000_28	This is an eye opening article says Dr.	thi eye open articl say dr
19981119131000000_29	Joseph LoCicero chief of general thoracic surgery at Beth Israel Deaconess Medical Center in Boston though it s unclear how many patients can benefit.	joseph l ocicero chief gener thorac surgeri beth israel deaco medic center boston though unclear mani patient benefit
19981119131000000_30	But he said I doubt there are a whole lot of surgeons who could do this at the moment.	said doubt whole lot surgeon could thi moment
19981120000000000_1	New Drug Combination Fights Hepatitis C.	new drug combin fight hepat c
19981120000000000_2	OTTAWA November 20 (Xinhua) People infected with hepatitis C may have a better chance of a cure after researchers in Canada discovered a new combination of drugs to treat the disease.	ottawa novemb xinhua peopl infect hepat c may better chanc cure research canada discov new combin drug treat diseas
19981120000000000_3	According to this week s New England Journal of Medicine six months after treatment patients who received the two drug combination were more likely to be free of hepatitis C than they would be if they accepted the traditional drug treatment of interferon.	accord thi week new england journal medicin six month treatment patient receiv two drug combin like free hepat c would accept tradit drug treatment interferon
19981120000000000_4	said Morris Sherman an assistant professor in medicine at the University of Toronto.	said morri sherman assist professor medicin univers toronto
19981120000000000_5	The key drug involved known as ribavirin has not been approved for official use in Canada but it is available throughout the country.	key drug involv known ribavirin ha approv offici use canada avail throughout countri
19981120000000000_6	The traditional drug interferon approved in Canada in 1991 has helped in 40 percent of the cases but the benefits are generally not long lasting as less than 15 percent of the patients achieve complete remission after the treatment.	tradit drug interferon approv canada ha help percent case benefit gener long last less percent patient achiev complet remiss treatment
19981120000000000_7	As part of an international group of researchers from the United States Australia Greece and Canada Dr.	part intern group research unit state australia greec canada dr
19981120000000000_8	Sherman conducted his study with 832 patients in Canada.	sherman conduct hi studi patient canada
19981120000000000_9	Six months after treatment 43 percent of those who undergone 48 weeks of combination therapy had undetectable levels of the virus compared to 19 percent of those on interferon alone.	six month treatment percent undergon week combin therapi undetect level viru compar percent interferon alon
19981120000000000_10	About 250 000 Canadians are infected with hepatitis C a blood borne virus spread in the same way as AIDS.	canadian infect hepat c blood born viru spread way aid
19981120183900000_1	Sex at a molecular level is spawning an elite class of proteins.	sex molecular level spawn elit class protein
19981120183900000_2	has used a DNA shuffling technique to create interferons that are dramatically more effective against viruses than any produced naturally by the immune system.	ha use dna shuffl techniqu creat interferon dramat effect virus ani produc natur immun system
19981120183900000_3	It has also made ultra efficient versions of an industrial enzyme.	ha also made ultra effici version industri enzym
19981120183900000_4	When organisms reproduce sexually the offspring end up with a mix and match set of genes inherited from both parents.	organ reproduc sexual offspr end mix match set gene inherit parent
19981120183900000_5	Maxygen s technique is similar except the parents are a series of related genes.	maxygen techniqu similar except parent seri relat gene
19981120183900000_6	These are cut into pieces shuffled together and then assembled to form a new genetic generation.	cut piec shuffl togeth assembl form new genet gener
19981120183900000_7	Some of these daughter genes can manufacture proteins that are much better at certain tasks than nature s originals.	daughter gene manufactur protein much better certain task natur origin
19981120183900000_8	The best ones can be screened out and shuffled to produce whole lineages of superior descendants in a process mimicking evolution by natural selection.	best one screen shuffl produc whole lineag superior descend process mimick evolut natur select
19981120183900000_9	Maxygen s technique was described earlier this year in Nature (vol.	maxygen techniqu wa describ earlier thi year natur vol
19981120183900000_10	The parent genes are first broken into fragments by shattering their DNA with ultrasound or cutting them up with an enzyme called DNAse.	parent gene first broken fragment shatter dna ultrasound cut enzym call dna se
19981120183900000_11	They are reassembled into daughter genes comprising fragments from several parents using a variant of the DNA building polymerase chain reaction.	reassembl daughter gene compris fragment sever parent use variant dna build polymeras chain reaction
19981120183900000_12	Short template or primer sequences ensure that the fragments are stitched together in the correct order to produce a functioning gene.	short templat primer sequenc ensur fragment stitch togeth correct order produc function gene
19981120183900000_13	The daughter genes can then be inserted into bacteria or fungi where they begin making protein.	daughter gene insert bacteria fungi begin make protein
19981120183900000_14	To make superior versions of an industrial enzyme the identity of which is still secret Maxygen s scientists isolated genes from 26 microorganisms which each make their own versions of the enzyme.	make superior version industri enzym ident still secret maxygen scientist isol gene microorgan make version enzym
19981120183900000_15	Using its system of DNA shuffling Maxygen made 600 new daughter genes 77 of which produced superior enzymes.	use system dna shuffl maxygen made new daughter gene produc superior enzym
19981120183900000_16	Screening showed up variants which functioned better than natural enzymes at high low or intermediate pH.	screen show variant function better natur enzym high low intermedi ph
19981120183900000_17	They re all highly significant commercially says Pim Stemmer Maxygen s vice president of research.	highli signific commerci say pim stemmer maxygen vice presid research
19981120183900000_18	Maxygen has also shuffled genes that make the 20 known human interferons.	maxygen ha also shuffl gene make known human interferon
19981120183900000_19	This time they made 2 000 daughter genes and once again the results were spectacular.	thi time made daughter gene onc result spectacular
19981120183900000_20	The best interferon produced by the genes was 285 000 times as potent as interferon alpha 2b which is marketed as a drug as measured by its ability to protect cultured cells against a mouse virus.	best interferon produc gene wa time potent interferon alpha b market drug measur abil protect cultur cell mous viru
19981120183900000_21	It could prove a major moneyspinner for Maxygen.	could prove jor money spinner maxygen
19981120183900000_22	Sales of interferon alpha 2b which is used to treat viral diseases and cancer pull in 600 million each year for Schering Plough of Berlin.	sale interferon alpha b use treat viral diseas cancer pull million year schere plough berlin
19981120183900000_23	At present the most popular method of coaxing genes into making new versions of proteins is random mutagenesis in which ultraviolet light or a DNA disrupting chemical makes genes mutate.	present popular method coax gene make new version protein random mutagenesi ultraviolet light dna di rupt chemic make gene mutat
19981120183900000_24	But most of these mutations are damaging with typically only 1 percent yielding genes that make improved proteins.	mutat damag typic onli percent yield gene make improv protein
19981120183900000_25	By comparison 13 percent of the enzymes Maxygen produced through DNA shuffling were superior.	comparison percent enzym maxygen produc dna shuffl superior
19981120183900000_26	DNA shuffling is a very powerful technology says Andy Ellington of the University of Texas at Austin who is currently comparing the technique with random mutagenesis.	dna shuffl veri power technolog say andi ellington univers texa austin current compar techniqu random mutagenesi
19981120183900000_27	It is not even necessary to know the identity of all the genes which might profitably be mated with one another Stemmer says.	even necessari know ident gene might profit mate one anoth stemmer say
19981120183900000_28	Fragments of DNA from a known gene can be used to trawl genomes of other species for related genes.	fragment dna known gene use trawl genom speci relat gene
19981120183900000_29	(This article is excerpted from New Scientist a weekly science and technology magazine based in London.	thi articl excerpt new scientist weekli scienc technolog magazin base london
19981122000000000_1	Drug Combination for Hepatitis C Proves Effective.	drug combin hepat c prove effect
19981122000000000_2	doctors said that a combination of two virus fighting drugs has proved considerably more effective against chronic hepatitis C infections than the standard single medicine said the Washington Post.	doctor said combin two viru fight drug ha prove consider effect chronic hepat c infect standard singl medicin said washington post
19981122000000000_3	In the United States nearly 4 million people are believed to have hepatitis C with about 10 000 deaths from the disease each year.	unit state nearli million peopl believ hepat c death diseas year
19981122000000000_4	The virus is the leading cause of chronic liver disease.	viru lead caus chronic liver diseas
19981122000000000_5	Typically only 15 percent to 20 percent of patients who get interferon are rid of all signs of the virus and most will eventually relapse.	typic onli percent percent patient get interferon rid sign viru eventu relaps
19981209224500000_1	FDA APPROVES WIDER USE OF LIVER DRUG.	fda approv wider use liver drug
19981209224500000_2	The Food and Drug Administration Wednesday approved the expanded use of Rebetron a treatment already on the market for hepatitis C a viral infection of the liver that can lead to cirrhosis liver cancer and liver failure.	food drug administr wednesday approv expand use rebetron treatment al readi market hepat c viral infect liver lead cirrhosi liver cancer liver failur
19981209224500000_3	Hepatitis C infects an estimated four million Americans and kills 8 000 to 10 000 a year.	hepat c infect estim four million american kill year
19981209224500000_4	The disease spread mainly by dirty needles and exposure to infected blood is the leading reason for liver transplants.	diseas spread mainli dirti needl exposur infect blood lead reason liver transplant
19981209224500000_5	was approved in June only for patients who had relapsed after taking interferon drugs the only other approved treatment for the disease.	wa approv june onli patient relaps take interferon drug onli approv treatment diseas
19981209224500000_6	The expanded approval now means that Rebetron can also be given to patients who had not taken interferon.	expand approv mean rebetron also given patient taken interferon
19981209224500000_7	The Rebetron treatment combines interferon injections with a second anti viral drug ribavirin which is swallowed in capsules.	rebetron treatment combin interferon inject second anti viral drug ribavirin swallow capsul
19981209224500000_8	By the end of October Rebetron sales had totaled 46 million according to IMS Health a firm that tracks the pharmaceutical industry.	end octob rebetron sale total million accord im health firm track pharmaceut industri
19981209224500000_9	The FDA cautioned that Rebetron is not a cure and that it is not known whether the treatment can delay the progression of liver disease caused by the virus.	fda caution rebetron cure known whether treatment delay progress liver diseas caus viru
19981209224500000_10	It suppresses blood levels of the virus far better than interferon alone.	suppress blood level viru far better interferon alon
19981209224500000_11	But researchers say that not all hepatitis C patients need Rebetron which can have severe side effects including flulike symptoms anemia depression and suicidal behavior.	research say hepat c patient need rebetron sever side effect includ flulik symptom anemia depress suicid behavior
19981209224500000_12	The expanded use was approved over the protests of patient advocates who object to the way Rebetron is being sold.	expand use wa approv protest patient advoc object way rebetron sold
19981209224500000_13	Interferon and ribavirin are sold together as a kit a practice known as bundling.	interferon ribavirin sold togeth kit practic known bundl
19981209224500000_14	Patients cannot get ribavirin without purchasing the entire kit.	patient cannot get ribavirin without purchas entir kit
19981209224500000_15	A Schering Plough spokesman Robert Consalvo said Rebetron is sold in this way because ribavirin has been approved for use only in combination with Schering s brand of interferon.	schere plough spokesman robert consalvo said rebetron sold thi way becaus ribavirin ha approv use onli combin schere brand interferon
19981209224500000_16	But some patients say that their doctors would like to prescribe ribavirin with another brand of interferon.	patient say doctor would like prescrib ribavirin anoth brand interferon
19981209224500000_17	And they accuse Schering of bundling the products in order to maintain the high price of the drugs and compel patients to use its interferon.	accus schere bundl product order maintain high price drug compel patient use interferon
19981209224500000_18	In another hepatitis treatment development Glaxo Wellcome and Biochem Pharma said Wednesday that the FDA had approved their drug lamivudine as the first oral therapy for the treatment of hepatitis B.	anoth hepat treatment develop glax well come biochem pharma said wednesday fda approv drug lamivudin first oral therapi treatment hepat b
19981209224500000_19	In the United States the drug will have a wholesale cost of 1 250 a year.	unit state drug wholesal cost year
19981209224500000_20	Lamivudine also known as 3TC and marketed under the trade name Epivir has previously been approved for the HIV virus for which it is the most commonly prescribed drug.	lamivudin also known tc market trade name epivir ha previous approv hiv viru commonli prescrib drug
19981209224500000_21	Epivir for AIDS will generate an estimated 800 million in revenue this year.	epivir aid gener estim million revenu thi year
19981209224500000_22	Hepatitis B affects many more people than AIDS perhaps as many as 350 million worldwide.	hepat b affect mani peopl aid perhap mani million worldwid
19981209224500000_23	Most of those patients are in Asian countries where the cost of the drug may be prohibitive so analysts say it is difficult to estimate the potential market.	patient asian countri cost drug may prohibit analyst say difficult estim potenti market
19981209224500000_24	But there are an estimated one million hepatitis B patients in North America and about twice that many in Europe where price is less of an issue.	estim one million hepat b patient north america twice mani europ price less issu
19981214185200000_1	Three years ago when Patricia Buchanan a 43 year old woman living in Brooklyn Park Minn.	three year ago patricia buchanan year old woman live brooklyn park minn
19981214185200000_2	consulted her doctor about fatigue and a vague feeling of illness she expected to be told that her problems were due to smoking and excess weight.	consult doctor fatigu vagu feel ill expect told problem due smoke excess weight
19981214185200000_3	She had probably been infected 15 or 20 years before her doctor said and like 85 percent of all patients she had developed a chronic infection.	probabl infect year befor doctor said like percent patient develop chronic infect
19981214185200000_4	The vast majority of people with chronic hepatitis C carry the virus indefinitely apparently with few ill effects.	vast joriti peopl chronic hepat c carri viru indefinit appar ill effect
19981214185200000_5	But about 20 percent develop cirrhosis and liver failure or cancer within 20 to 25 years of being infected.	percent develop cirrhosi liver failur cancer within year infect
19981214185200000_6	The infection causes 8 000 to 10 000 deaths per year in the United States and it has become the leading reason for liver transplants.	infect caus death per year unit state ha becom lead reason liver transplant
19981214185200000_7	Buchanan s lab tests and a biopsy revealed scarring of the liver indicating that she might be one of the unfortunate ones in whom the disease would worsen.	buchanan lab test biopsi reveal scar liver indic might one unfortun one diseas would worsen
19981214185200000_8	Hoping to prevent further liver damage her doctor recommended drug treatment to try to rid her system of the virus.	hope prevent liver damag doctor recommend drug treatment tri rid system viru
19981214185200000_9	Buchanan who has four grown children and runs her own business a ceramics studio had never even heard of hepatitis C.	buchanan ha four grown children run busi ceram studio never even heard hepat c
19981214185200000_10	During the next two decades many more Americans are expected to find themselves in the same situation.	dure next two decad mani american expect find themselv situat
19981214185200000_11	Most will be middle aged people who feel fine now but who will become ill as Mrs.	middl age peopl feel fine becom ill mr
19981214185200000_12	Others will receive letters from the government and blood banks as part of a program to inform 300 000 people who may have been infected by transfusions before 1992 when a test for the hepatitis C virus came into use.	receiv letter govern blood bank part program inform peopl may infect transfus befor test hepat c viru came use
19981214185200000_13	Buchanan with clear signs of liver damage doctors strongly recommend treatment.	buchanan clear sign liver damag doctor strongli recommend treatment
19981214185200000_14	But those who test positive for the virus but have no signs of disease will face difficult questions about whether to start treatment because it is expensive complicated by severe side effects and in more than half of patients unable to eradicate the virus.	test posit viru sign diseas face difficult question whether start treatment becaus expens complic sever side effect half patient unabl erad viru
19981214185200000_15	Treatment is generally not recommended for those without signs of liver damage but regular monitoring is because in the early stages of infection it is impossible to tell whether the disease will progress.	treatment gener recommend without sign liver damag regular monitor becaus earli stage infect imposs tell whether diseas progress
19981214185200000_16	The federal Centers for Disease Control and Prevention estimates that four million Americans are infected with hepatitis C and most of them do not know they are carrying it.	feder center diseas control prevent estim four million american infect hepat c know carri
19981214185200000_17	Those who know they need treatment may find themselves caught in a controversy similar to the ones that have erupted over high priced treatments for AIDS.	know need treatment may find themselv caught controversi similar one erupt high price treatment aid
19981214185200000_18	Their interests have collided with those of a pharmaceutical company eager to recoup its research expenses and turn a profit.	interest collid pharmaceut compani eager recoup research expens turn profit
19981214185200000_19	Meanwhile some researchers say that the company Schering Plough Corp.	mean research say compani schere plough corp
19981214185200000_20	Hepatitis C is spread mainly by exposure to infected blood.	hepat c spread mainli exposur infect blood
19981214185200000_21	Before the test for the virus came into use transfusions were the main route of transmission.	befor test viru came use transfus main rout transmiss
19981214185200000_22	Since then the number of new infections has plummeted.	sinc number new infect ha plummet
19981214185200000_23	But Schering has called the disease an epidemic and has featured on its Web site illustrations of people with the hideously yellow eyes of jaundice a symptom of severe liver disease.	schere ha call diseas epidem ha featur web site illustr peopl hideous yellow eye jaundic symptom sever liver diseas
19981214185200000_24	To put it bluntly the ads say every living breathing human being can get hepatitis C even you.	put bluntli ad say everi live breath human get hepat c even
19981214185200000_25	The Lancet a British medical journal says the advertising campaign has breached the public trust.	lancet british medic journal say advertis campaign ha breach public trust
19981214185200000_26	But in a telephone interview Robert Consalvo a spokesman for Schering said the word epidemic was reasonable given that hepatitis C infects 4 million Americans and is the leading blood borne infection in the nation.	telephon interview robert consalvo spokesman schere said word epidem wa reason given hepat c infect million american lead blood born infect nation
19981214185200000_27	Leonard Seeff a senior scientist for hepatitis C research at the National Institute of Diabetes and Digestive Diseases said The inference from the word epidemic is that people are getting infected like crazy and that s not so.	leonard seeff senior scientist hepat c research nation institut diabet digest diseas said infer word epidem peopl get infect like crazi
19981214185200000_28	Seeff said he worried that fears about the disease and the pressure to test and treat everyone would lead people infected with the virus to take expensive drugs with potentially serious side effects whether they need them or not.	seeff said worri fear diseas pressur test treat everyon would lead peopl infect viru take expens drug potenti seriou side effect whether need
19981214185200000_29	He said more than 80 percent of those infected with the virus will survive with no disease whatsoever.	said percent infect viru surviv diseas whatsoev
19981214185200000_30	But he added that people with the virus must never drink alcohol because it accelerates liver damage from the infection.	ad peopl viru must never drink al cohol becaus acceler liver damag infect
19981214185200000_31	Consalvo said Schering scientists believe that the earlier patients start treatment the better their chances of getting rid of the virus.	consalvo said schere scientist believ earlier patient start treatment better chanc get rid viru
19981214185200000_32	Jay Hoofnagle director of the division of digestive diseases and nutrition at the National Institutes of Health said.	jay hoof nagl director divis digest diseas nutrit nation institut health said
19981214185200000_33	New cases have fallen precipitously since the discovery of the virus.	new case fallen precipit sinc discoveri viru
19981214185200000_34	The epidemic if it occurred occurred during the 60s and 70s when there was a lot of experimentation with drugs and the virus got into the population that donated blood.	epidem occur occur dure wa lot experiment drug viru got popul donat blood
19981214185200000_35	People infected then are now turning 50 and 60 at which point hepatitis C rears its head.	peopl infect turn point hepat c rear head
19981214185200000_36	Because some of those people will fall ill a substantial increase is expected in the demand for liver transplants though donor organs are already in short supply.	becaus peopl fall ill substanti increas expect demand liver transplant though donor organ al readi short suppli
19981214185200000_37	Hepatitis deaths are also expected to increase possibly doubling or tripling to 20 000 or 30 000 a year within a decade or so.	hepat death also expect increas possibl doubl tripl year within decad
19981214185200000_38	But the number of deaths will probably peak and then decline again because of the decline in new infections Seeff said.	number death probabl peak declin becaus declin new infect seeff said
19981214185200000_39	According to a CDC report issued in October there were an estimated 230 000 new infections each year through the 1980s.	accord cdc report issu octob estim new infect year
19981214185200000_40	Today the most common means of transmission is the sharing of needles by drug users which accounts for 60 percent of new infections in the United States.	today common mean transmiss share needl drug user account percent new infect unit state
19981214185200000_41	Among those who have injected drugs for five years 90 percent are thought to be infected.	among inject drug five year percent thought infect
19981214185200000_42	The origin of the remaining 40 percent of infections is less clear.	origin remain percent infect less clear
19981214185200000_43	Although sexual contact does not seem to spread hepatitis C efficiently (unlike the AIDS and hepatitis B viruses) 20 percent of infected people report no other means of exposure.	although sexual contact doe seem spread hepat c effici unlik aid hepat b virus percent infect peopl report mean exposur
19981214185200000_44	Another 10 percent are thought to have been infected while working at a hospital undergoing hemodialysis for kidney failure during birth or by sharing a toothbrush or razor or being exposed in some other way to infected blood.	anoth percent thought infect work hospit undergo hemodialysi kidney failur dure birth share toothbrush razor expos way infect blood
19981214185200000_45	Despite widespread warnings about tattooing and body piercing and the common sense assumption that dirty instruments could spread the virus the CDC says there is no evidence linking those practices to the disease in the United States.	despit wide pread warn tattoo bodi pierc common sens assumpt dirti instrument could spread viru cdc say evid link practic diseas unit state
19981214185200000_46	Similarly many doctors suspect that people can transmit the virus by sharing straws used to inhale cocaine but researchers are not sure whether that has occurred.	similarli mani doctor suspect peopl transmit viru share straw use inhal cocain research sure whether ha occur
19981214185200000_47	Buchanan said she belongs to the no explanation group having never received a transfusion or taken drugs.	buchanan said belong explan group never receiv transfus taken drug
19981214185200000_48	Her husband and other family members all tested negative for the virus she said.	husband famili member test neg viru said
19981214185200000_49	Buchanan enrolled in a study that provided six months of treatment with Schering Plough s version of the drug interferon which eliminates the virus in 10 to 20 percent of patients.	buchanan enrol studi provid six month treatment schere plough version drug interferon elimin viru percent patient
19981214185200000_50	At the time interferon was the only treatment available.	time interferon wa onli treatment avail
19981214185200000_51	In June a new treatment was approved by the Food and Drug Administration a combination therapy that paired interferon with the antiviral drug ribavirin.	june new treatment wa approv food drug administr combin therapi pair interferon antivir drug ribavirin
19981214185200000_52	The combination Rebetron made by Schering Plough reduced the virus to undetectable levels in about twice as many patients as interferon did.	combin rebetron made schere plough reduc viru undetect level twice mani patient interferon
19981214185200000_53	nn Even when it worked Rebetron was not considered a cure and it had terrible side effects including anemia depression suicidal thoughts and severe flu like symptoms.	nn even work rebetron wa consid cure terribl side effect includ anemia depress suicid thought sever flu like symptom
19981214185200000_54	But because Schering Plough s brand of interferon had not worked for her she hoped to purchase the ribavirin alone and combine it with another form of interferon a slightly different one made by another company.	becaus schere plough brand interferon work hope purchas ribavirin alon combin anoth form interferon slightli differ one made anoth compani
19981214185200000_55	Schering Plough had bundled the two drugs packaging them together as a kit.	schere plough bundl two drug packag togeth kit
19981214185200000_56	Patients could buy Schering s interferon alone but not ribavirin.	patient could buy schere interferon alon ribavirin
19981214185200000_57	A company spokesman said the product was packaged that way because there was no approved use for ribavirin except in combination with interferon as a treatment for hepatitis C.	compani spokesman said product wa packag way becaus wa approv use ribavirin except combin interferon treatment hepat c
19981214185200000_58	Because Schering Plough had the exclusive right to market ribavirin in the United States there was no other way to buy it.	becaus schere plough exclus right market ribavirin unit state wa way buy
19981214185200000_59	Buchanan did not want to purchase the entire kit a six month supply costs 6 400 to 8 600 just to get the ribavirin.	buchanan want purchas entir kit six month suppli cost get ribavirin
19981214185200000_60	A spokesman for Schering said the price of Rebetron reflected the hundreds of millions of dollars it has cost to develop the product.	spokesman schere said price rebetron reflect hundr million dollar ha cost develop product
19981214185200000_61	The bundling of Rebetron which might seem a stroke of marketing genius to a drug company looked like a dangerous precedent to people with hepatitis C.	bundl rebetron might seem stroke market geniu drug compani look like danger preced peopl hepat c
19981214185200000_62	Buchanan wanted to mix ribavirin with another company s interferon and some particularly people who had received liver transplants needed smaller doses of interferon than the kit provided but would be forced to throw away the extra medication because it was perishable.	buchanan want mix ribavirin anoth compani interferon particularli peopl receiv liver transplant need smaller dose interferon kit provid would forc throw away extra medic becaus wa perish
19981214185200000_63	The bundling also sent up a red flag among advocates for AIDS patients.	bundl also sent red flag among advoc aid patient
19981214185200000_64	Some people taking a host of drugs to treat HIV also have hepatitis C and want as much flexibility as possible in picking medications.	peopl take host drug treat hiv also hepat c want much flexibl possibl pick medic
19981214185200000_65	The AIDS groups began showing hepatitis patients how to do battle with big drug companies.	aid group began show hepat patient battl big drug compani
19981214185200000_66	Jeff Getty who is active in AIDS issues in San Francisco said The HIV and AIDS community is watching this and very much up in arms about it because we know what it means for us.	jeff getti activ aid issu san francisco said hiv aid commun watch thi veri much arm becaus know mean us
19981214185200000_67	Getty said he feared that companies would similarly bundle combination treatments for AIDS interfering with doctors ability to prescribe different combinations for patients.	getti said fear compani would similarli bundl combin treatment aid interf doctor abil prescrib differ combin patient
19981214185200000_68	One AIDS group has begun buying ribavirin from Mexico which imports it from a U.	one aid group ha begun buy ribavirin mexico import u
19981214185200000_69	The group provides it to hepatitis C patients at cost which comes to less than half what ribavirin would cost in the bundled product.	group provid hepat c patient cost come less half ribavirin would cost bundl product
19981214185200000_70	Patients and advocacy groups asked the FDA to require that Rebetron be unbundled but Dr.	patient advocaci group ask fda requir rebetron unbundl dr
19981214185200000_71	Heidi Jolson director of the division of antiviral drugs at the agency said its lawyers had determined that it lacked the regulatory authority to do so.	heidi jolson director divis antivir drug agenc said lawyer determin lack regulatori author
19981214185200000_72	Jolson did write to Schering Plough saying that the product did not have to be bundled and that the agency would cooperate if the company decided to sell the drugs separately.	jolson write schere plough say product bundl agenc would cooper compani decid sell drug separ
19981214185200000_73	Consalvo said Schering Plough has listened to the concerns of patient advocates and is developing a program to help provide ribavirin to hepatitis patients whose doctors can prove that the patients have a need for it.	consalvo said schere plough ha listen concern patient advoc develop program help provid ribavirin hepat patient whose doctor prove patient need
19981214185200000_74	The program will start in January he said though patients who need help sooner may get it if their doctors contact the company.	program start januari said though patient need help sooner may get doctor contact compani
19981214185200000_75	Buchanan who said her letter to the company had never been answered.	buchanan said letter compani never answer
19990301195000000_1	FDA REJECTS SERONO LAB S DRUG FOR MS.	fda reject serono lab drug ms
19990301195000000_2	suffered a major blow Monday by failing to obtain permission from the federal government to sell its multiple sclerosis drug in the United States.	suffer jor blow monday fail obtain permiss feder govern sell multipl sclerosi drug unit state
19990301195000000_3	The decision by the US Food and Drug Administration marks a major victory for Biogen Inc.	decis us food drug administr mark jor victori biogen inc
19990301195000000_4	million a year market for multiple sclerosis treatment.	million year market multipl sclerosi treatment
19990301195000000_5	manufacture beta interferon a drug used to slow down the debilitating neurological disease.	manufactur beta interferon drug use slow debilit neurolog diseas
19990301195000000_6	Biogen s drug is called Avonex and has been on the US market since 1996 while Serono makes Rebif.	biogen drug call avonex ha us market sinc serono make rebif
19990301195000000_7	In its ruling delivered to Serono on Friday and disclosed Monday the FDA said Biogen maintains the exclusive right to sell beta interferon in the United States until 2003 under the Orphan Drug Act a law that grants marketing exclusivity to companies that develop drugs for certain rare diseases including multiple sclerosis.	rule deliv serono friday disclos monday fda said biogen maintain exclus right sell beta interferon unit state orphan drug act law grant market exclus compani develop drug certain rare diseas includ multipl sclerosi
19990301195000000_8	As today s FDA ruling makes clear Rebif does not offer greater efficacy or safety and does not provide a significant addition to patient care said Jim Vincent Biogen s chairman and chief executive.	today fda rule make clear rebif doe offer greater efficaci safeti doe provid signific addit patient care said jim vincent biogen chairman chief execut
19990301195000000_9	The decision however technically leaves the door open for Serono to obtain a waiver from the Orphan Drug Act by demonstrating that Rebif is clinically superior to Avonex.	decis howev technic leav door open serono obtain waiver orphan drug act demonstr rebif clinic superior avonex
19990301195000000_10	So far Serono has spent more than 100 million to develop the drug which is only available in Canada and Europe.	far serono ha spent million develop drug onli avail canada europ
19990301195000000_11	Serono has tried to argue so far to no avail that Rebif is different from Avonex in three ways.	serono ha tri argu far avail rebif differ avonex three way
19990301195000000_12	While Avonex must be mixed with a sterile solution before it is injected into the muscle Rebif comes pre mixed in syringes for injections beneath the skin.	avonex must mix steril solut befor inject muscl rebif come pre mix syring inject beneath skin
19990301195000000_13	More importantly Serono said Rebif comes in several doses while Avonex is only approved for one dose.	importantli serono said rebif come sever dose avonex onli approv one dose
19990301195000000_14	Serono executives have argued that stronger doses of beta interferon work better for patients with more advanced multiple sclerosis.	serono execut argu stronger dose beta interferon work better patient advanc multipl sclerosi
19990301195000000_15	Its research however did not include head to head trials comparing Avonex and Rebif.	research howev includ head head trial compar avonex rebif
19990301195000000_16	Serono will continue its discussions with the FDA on the outstanding orphan drug issues to determine how it can make Rebif available to MS patients as soon as possible said Hisham Samra Serono Laboratories president.	serono continu discuss fda stand orphan drug issu determin make rebif avail ms patient soon possibl said hisham samra serono laboratori presid
19990301195000000_17	Serono is a subsidiary of the Geneva based Ares Serono Group the world s largest fertility drug maker.	serono subsidiari geneva base serono group world largest fertil drug maker
19990301195000000_18	Biogen s stock soared 6 1 8 Monday on the Nasdaq to 102 1 4 on anticipation of the FDA ruling which was not made until after the stock market closed.	biogen stock soar monday nasdaq anticip fda rule wa made stock market close
19990329171900000_1	BALANCED IMMUNE RESPONSE MAY FIGHT EBOLA.	balanc immun respons may fight ebola
19990329171900000_2	The early moments after patients are infected with the feared Ebola virus may be the most important to their survival researchers report this week in the journal Nature Medicine.	earli moment patient infect fear ebola viru may import surviv research report thi week journal natur medicin
19990329171900000_3	A French team working in Gabon in West Africa have successfully taken and analyzed blood samples from 11 patients infected during outbreaks in Gabon and the Congo.	french team work gabon west africa success fulli taken analyz blood sampl patient infect dure break gabon congo
19990329171900000_4	This is in itself a feat because outbreaks have so far only taken place in very remote areas and because those who contract the disease die swiftly.	thi feat becaus break far onli taken place veri remot area becaus contract diseas die swiftli
19990329171900000_5	Ebola is a rare viral disease confined to occasional outbreaks in Africa since its first appearance in 1979.	ebola rare viral diseas confin occasion break africa sinc first appear
19990329171900000_6	But this exotic virus gets attention disproportionate to its human toll for two reasons.	thi exot viru get attent disproportion human toll two reason
19990329171900000_7	First the virus kills 70 percent of those it infects and kills horribly with the disease advancing from fever to massive bloody hemorrhaging in a space of 10 days.	first viru kill percent infect kill horribl diseas advanc fever massiv bloodi hemorrhag space day
19990329171900000_8	Second researchers worry that Ebola may not remain forever in its remote jungle confines but may one day break out.	second research worri ebola may remain forev remot jungl confin may one day break
19990329171900000_9	Leroy of the International Center for Medical Research in Gabon the team found a striking difference in the first days of the infection between those who would eventually die and those who would survive.	leroy intern center medic research gabon team found strike differ first day infect would eventu die would surviv
19990329171900000_10	Of the 11 patients from whom blood was taken four survived and are now believed immune to further Ebola infection.	patient blood wa taken four surviv believ immun ebola infect
19990329171900000_11	They discovered that the immune defenses in the two groups were quite distinct.	discov immun defens two group quit distinct
19990329171900000_12	The immune system puts up two general types of defense against invading microbes.	immun system put two gener type defens invad microb
19990329171900000_13	In one the humoral system antibodies identify and latch on to the invading bugs.	one humor system antibodi identifi latch invad bug
19990329171900000_14	In the other the cellular system defenders spot cells that the invading bugs have infected.	cellular system defend spot cell invad bug infect
19990329171900000_15	Among the surviving patients the immune defenses were stable enough to produce a good humoral response including antibodies to attack the virus as well as a good cellular response including a substantial number of killer cells (or cytotoxic T cells) and modest amounts of interferon the body s own antiviral substance.	among surviv patient immun defens stabl enough produc good humor respons includ antibodi attack viru well good cellular respons includ substanti number killer cell cytotox cell modest amount interferon bodi antivir substanc
19990329171900000_16	Thus there appeared to be a balanced attack from both humoral and cellular defenses.	thu appear balanc attack humor cellular defens
19990329171900000_17	These patients were able to clear much of the Ebola out of their blood then continued to produce both killer cells and interferon to suppress further multiplication of the viruses.	patient abl clear much ebola blood continu produc killer cell interferon suppress multipl virus
19990329171900000_18	By contrast the immune systems of the majority those who did not survive the infection failed to give a balanced defense within the first two to three days after infection.	contrast immun system joriti surviv infect fail give balanc defens within first two three day infect
19990329171900000_19	They had a poor showing of antibodies but at the same time apparently produced too much of the cellular kind of defense as signaled by excessive production of interferon.	poor show antibodi time appar produc much cellular kind defens signal excess product interferon
19990329171900000_20	One possibility is that the too strong response of one part of the immune system may be giving falsely strong signals thereby passing information that would suppress the other side of the defense.	one possibl strong respons one part immun system may give fals strong signal therebi pass inform would suppress side defens
19990329171900000_21	Or possibly the patient was infected by so much virus that it overwhelmed one half of the immune system s defenses.	possibl patient wa infect much viru whelm one half immun system defens
19990329171900000_22	The lack of one kind of defense and excess of another suggests that a good strategy to attack Ebola infection may be to intervene in the body to balance the two kinds of defenses by enhancing one or depressing the other.	lack one kind defens excess anoth suggest good strategi attack ebola infect may interven bodi balanc two kind defens enhanc one depress
19990329171900000_23	Russell emeritus professor at the Johns Hopkins School of Public Health said the work represented an important step in understanding how Ebola works.	russel emeritu professor john hopkin school public health said work repres import step understand ebola work
19990329171900000_24	Pierre Rollin of the Special Pathogens Branch at the federal Centers for Disease Control said the work would help researchers test ideas.	pierr rollin special pathogen branch feder center diseas control said work would help research test idea
19990329171900000_25	For example therapies that would suppress the interferon production and related cellular immune defenses might now be put at the top of the list to try he said.	exampl therapi would suppress interferon product relat cellular immun defens might put top list tri said
19990329171900000_26	But therapies that used interferon as a treatment might be ruled out.	therapi use interferon treatment might rule
19990411144411000_1	LONDON (AP) Glaxo Wellcome PLC today released new data indicating its drug Zeffix may help prevent chronic hepatitis B sufferers from developing cirrhosis.	london ap glax well come plc today releas new data indic drug zeffix may help prevent chronic hepat b suffer develop cirrhosi
19990411144411000_2	The data from three large clinical studies showed a smaller proportion of chronic hepatitis B patients treated with Zeffix progressed to cirrhosis or liver scarring compared with those treated with placebo or interferon alpha.	data three larg clinic studi show smaller proport chronic hepat b patient treat zeffix progress cirrhosi liver scar compar treat placebo interferon alpha
19990411144411000_3	The results were presented at the annual meeting of the European Association for the Study of the Liver in Naples and supported by other data showing additional Zeffix benefits Glaxo said.	result present annual meet european associ studi liver napl support data show addit zeffix benefit glax said
19990411144411000_4	8 percent of Zeffix treated patients progressed to cirrhosis compared with 7.	percent zeffix treat patient progress cirrhosi compar
19990411144411000_5	Glaxo said the results showed a continued increase in the incidence of e antigen seroconversion an immune response to the virus that is thought to predict long lasting remission of the disease and a continued reduction in levels of viral replication.	glax said result show continu increas incid e antigen seroconvers immun respons viru thought predict long last remiss diseas continu reduct level viral replic
19990411144411000_6	and approved in China Hong Kong Thailand Pakistan and New Zealand.	approv china hong kong thailand pakistan new zealand
19990411144411000_7	Regulatory applications have been made in Korea Taiwan Japan and Europe.	regulatori applic made korea taiwan japan europ
19990411144411000_8	Hepatitis B is a potentially fatal liver disease the ninth most common killer worldwide.	hepat b potenti fatal liver diseas ninth common killer worldwid
19990411144411000_9	About 350 million people are long term carriers of the hepatitis B virus and nearly one third are expected to develop progressive inflammation of the liver leading to cirrhosis and liver cancer.	million peopl long term carrier hepat b viru nearli one third expect develop progress inflamm liver lead cirrhosi liver cancer
19990411144411000_10	Previously therapies for chronic hepatitis B were limited to interferons which are injected and can lead to unpleasant side effects.	previous therapi chronic hepat b limit interferon inject lead unplea ant side effect
19990511110000000_1	Last week the Centers for Disease Control and Prevention kicked off Hepatitis Awareness Month.	last week center diseas control prevent kick hepat awar month
19990511110000000_2	The chronic potentially deadly liver disease infects 4 million of us and half don t even know they have it.	chronic potenti deadli liver diseas infect million us half even know
19990511110000000_3	People who had blood transfusions before 1992 and a trickier group healthy tax paying PTA involved soccer moms and dads entrenched in the suburbs.	peopl blood transfus befor trickier group healthi tax pay pta involv soccer mom dad entrench suburb
19990511110000000_4	Twenty or 30 years ago they flirted with peace and love and pass the needle while trying cocaine heroin or speed.	twenti year ago flirt peac love pass needl tri cocain heroin speed
19990511110000000_5	Hepatitis C can kill liver cells and cause scarring called cirrhosis.	hepat c kill liver cell caus scar call cirrhosi
19990511110000000_6	Last year there were 4 100 transplants with twice that many people waiting for a new liver.	last year transplant twice mani peopl wait new liver
19990511110000000_7	Acting as the nation s ever cautious school nurse the CDC has labeled hepatitis C an emerging chronic disease of great public health concern.	act nation ever cautiou school nurs cdc ha label hepat c emerg chronic diseas great public health concern
19990511110000000_8	This month s Redbook magazine calls it the next deadly epidemic.	thi month redbook magazin call next deadli epidem
19990511110000000_9	Last month s New York magazine wondered if it was the new AIDS.	last month new york magazin wonder wa new aid
19990511110000000_10	Doctors have climbed aboard with hepatitis C storylines.	doctor climb aboard hepat c storylin
19990511110000000_11	Experts say hepatitis C is less an epidemic than an epidemic of discovery says Dr.	expert say hepat c less epidem epidem discoveri say dr
19990511110000000_12	People infected 20 or 30 years ago are now discovering they may have a problem.	peopl infect year ago discov may problem
19990511110000000_13	Disposable needles and blood screening for transfusions have cut new cases of the C virus from 240 000 a year through the 80s to less than 30 000 a year today but past undiscovered cases have prompted the CDC s current push.	dispos needl blood screen transfus cut new case c viru year less year today past undiscov case prompt cdc current push
19990511110000000_14	Once you say epidemic the concern among the public is Good Lord around the corner there s a virus lurking and I m going to get it.	onc say epidem concern among public good lord around corner viru lurk go get
19990511110000000_15	That s not the case says Seeff the NIH s senior scientist for hepatitis C research.	case say seeff nih senior scientist hepat c research
19990511110000000_16	Eugene Schiff one of the nation s top liver doctors in his office at the University of Miami Medical School and he lays out the facts.	eugen schiff one nation top liver doctor hi offic univers miami medic school lay fact
19990511110000000_17	Let me tell you the typical case of hepatitis C right now says Schiff director of UM s Center for Liver Diseases.	let tell typic case hepat c right say schiff director um center liver diseas
19990511110000000_18	Between 40 and 50 often mainstream America very successful people.	often mainstream america veri success ful peopl
19990511110000000_19	But go back in time back when they were 16 or 17 and that person shared a needle.	go back time back person share needl
19990511110000000_20	As they got older they went on to college many were blood donors wanted to help out the community.	got older went colleg mani blood donor want help commun
19990511110000000_21	Not until 1990 after some of these people had been giving blood for many many years did they go into the blood bank and get a screening test.	peopl give blood mani mani year go blood bank get screen test
19990511110000000_22	This is how it turns out when you really talk to these people establish confidence.	thi turn realli talk peopl establish confid
19990511110000000_23	Some CEO of a company isn t going to tell you he ever played around with drugs.	ceo compani go tell ever play around drug
19990511110000000_24	In one painful way the hepatitis C scare resembles the early years of AIDs research so much hysteria so few facts.	one pain way hepat c scare resembl earli year aid research much hysteria fact
19990511110000000_25	It has to get in through a skin barrier or through some open cut.	ha get skin barrier open cut
19990511110000000_26	What is mystical is trying to define the actual specific methods of transfer.	mystic tri defin actual specif method transfer
19990511110000000_27	No one so far is 100 percent sure but the major risks remain needles and transfusions (before 1992) with tainted blood.	one far percent sure jor risk remain needl transfus befor taint blood
19990511110000000_28	There is no data to show that piercings tattoos or sex cause risks.	data show pierc tattoo sex caus risk
19990511110000000_29	We don t recommend anyone who had a tattoo be tested says Dr.	recommend anyon tattoo test say dr
19990511110000000_30	And it would be very very very unlikely that someone who got their ears pierced by a gun in a mall got hepatitis from that says Buffington.	would veri veri veri unlik someon got ear pierc gun mall got hepat say buffington
19990511110000000_31	The CDC advises safe sex if one partner is infected until more facts arrive.	cdc advis safe sex one partner infect fact arriv
19990511110000000_32	Only now is the CDC paying for a three year study of 1 000 sex partners one infected one not to see if sexual transmission is a risk.	onli cdc pay three year studi sex partner one infect one see sexual transmiss risk
19990511110000000_33	Of the 4 million Americans estimated to have been infected it s estimated that 30 000 will die by 2010 because of liver disease caused by chronic hepatitis C virus.	million american estim infect estim die becaus liver diseas caus chronic hepat c viru
19990511110000000_34	For 15 to 20 percent of people infected with hepatitis C the virus simply goes away.	percent peopl infect hepat c viru simpli goe away
19990511110000000_35	The other 80 to 85 percent develop chronic hepatitis C and it takes 20 years or more for 20 percent of them to develop cirrhosis and then the big problems can begin.	percent develop chronic hepat c take year percent develop cirrhosi big problem begin
19990511110000000_36	But less than 5 percent of people who develop cirrhosis eventually need a liver transplant.	less percent peopl develop cirrhosi eventu need liver transplant
19990511110000000_37	In the big picture it isn t a huge number says Buffington at the CDC.	big pictur huge number say buffington cdc
19990511110000000_38	Many many more people are dying of lung cancer.	mani mani peopl die lung cancer
19990511110000000_39	People with chronic hepatitis C have two choices if and when their livers begin to act up.	peopl chronic hepat c two choic liver begin act
19990511110000000_40	Raymond Grasso a 40 year old Port St.	raymond grasso year old port st
19990511110000000_41	construction worker chose treatment even though it makes him feel sicker than his hepatitis C ever did.	construct worker chose treatment even though make feel sicker hi hepat c ever
19990511110000000_42	I was always rundown and tired like I always had a hangover says Grasso.	wa alway rundown tire like alway hangov say grasso
19990511110000000_43	I drank enough alcohol to ruin my liver.	drank enough al cohol ruin liver
19990511110000000_44	Grasso who quit drinking four years ago had a liver biopsy.	grasso quit drink four year ago liver biopsi
19990511110000000_45	His hepatitis C had not yet caused long term liver damage but his liver was inflamed.	hi hepat c yet caus long term liver damag hi liver wa inflam
19990511110000000_46	He felt it was just a matter of time before he got liver disease.	felt wa matter time befor got liver diseas
19990511110000000_47	It s a question of whether you want to live or die he says.	question whether want live die say
19990511110000000_48	A combination of two powerful drugs interferon and ribavirin taken for six months to a year.	combin two power drug interferon ribavirin taken six month year
19990511110000000_49	A 40 percent chance to rid his body of hepatitis C.	percent chanc rid hi bodi hepat c
19990511110000000_50	Three times a week Grasso injects interferon under his skin.	three time week grasso inject interferon hi skin
19990511110000000_51	It s almost guaranteed the day after an injection I have flu like symptoms a fever.	almost guarante day inject flu like symptom fever
19990511110000000_52	a pain pill twice daily a blood pressure pill and sleeping pill.	pain pill twice daili blood pressur pill sleep pill
19990511110000000_53	He also takes a handful of vitamins and herbal medicines that won t hurt him but might help.	also take hand ful vitamin herbal medicin hurt might help
19990511110000000_54	For the interferon and ribavirin Grasso s HMO paid 1 831 for a six week supply.	interferon ribavirin grasso hmo paid six week suppli
19990511110000000_55	Depending on results he ll need the drugs for three months to a year.	depend result need drug three month year
19990511110000000_56	By the end of the week I m pretty much out of it says Grasso.	end week pretti much say grasso
19990511110000000_57	For a 40 percent shot at getting rid of the virus Grasso must endure months of suffering.	percent shot get rid viru grasso must endur month suffer
19990511110000000_58	Judy Van Tuyl made a different choice.	judi van tuyl made differ choic
19990511110000000_59	The 54 year old Fort Lauderdale woman was infected with chronic hepatitis C from a blood transfusion either after her serious car accident in 1966 or several hip operations before 1990.	year old fort lauderdal woman wa infect chronic hepat c blood transfus either seriou car accid sever hip oper befor
19990511110000000_60	She like Grasso burned up the Internet for hepatitis information.	like grasso burn internet hepat inform
19990511110000000_61	She read about one of several new treatments being tested PEG Intron A that may work faster with fewer side effects than the two drug combination that Grasso is taking.	read one sever new treatment test peg intron may work faster fewer side effect two drug combin grasso take
19990511110000000_62	Eventually in 10 to 15 years there may be a vaccine experts predict.	eventu year may vaccin expert predict
19990511110000000_63	This is a slow moving disease so maybe waiting a year is the thing to do.	thi slow move diseas may wait year thing
19990511110000000_64	She doesn t like the odds of success 10 to 40 percent with interferon and ribavirin.	like odd success percent interferon ribavirin
19990511110000000_65	And her neighbor who unsuccessfully tried interferon has told her about the gruesome side effects.	neighbor unsuccess fulli tri interferon ha told grue side effect
19990511110000000_66	With the hepatitis C hysteria comes another similarity to the dark days of AIDs shame.	hepat c hysteria come anoth similar dark day aid shame
19990511110000000_67	We re dealing with a tremendous stigma says Thelma King Thiel CEO of the Hepatitis Foundation International based in Cedar Grove N.	deal tremend stigma say thelma king thiel ceo hepat foundat intern base cedar grove n
19990511110000000_68	It s common for doctors to advise patients not to tell anyone they re infected.	common doctor advis patient tell anyon infect
19990511110000000_69	We have to peel people off the ceiling all the time because of all the negative stuff that s out there says Thiel.	peel peopl ceil time becaus neg stuff say thiel
19990511110000000_70	Kicking off the controversy late last year was a drug maker s Web site calling hepatitis C an epidemic.	kick controversi late last year wa drug maker web site call hepat c epidem
19990511110000000_71	featured pictures of ghastly jaundiced people with the message.	featur pictur ghastli jaundic peopl messag
19990511110000000_72	To put it bluntly every living breathing human being can get hepatitis C even you.	put bluntli everi live breath human get hepat c even
19990511110000000_73	Schering Plough is the maker of Intron A (interferon) and Rebetol (ribavirin) the drugs used together at a cost of about 300 a week to rid the body of the chronic C virus in some patients.	schere plough maker intron interferon rebetol ribavirin drug use togeth cost week rid bodi chronic c viru patient
19990511110000000_74	Also the American Liver Foundation came under fire for a hepatitis warning billboard in Sacramento featuring a coffin with the message.	also american liver foundat came fire hepat warn billboard sacramento featur coffin messag
19990511110000000_75	This space reserved for victims of hepatitis C.	thi space reserv victim hepat c
19990511110000000_76	Overly dramatic and untrue says Seeff of the NIH.	overli dramat untru say seeff nih
19990511110000000_77	Even without a vaccine and without good treatment he says most of the people infected are going to die from the diseases most of us will die from heart disease lung disease alcohol trauma gun shots and God knows what.	even without vaccin without good treatment say peopl infect go die diseas us die heart diseas lung diseas al cohol trauma gun shot god know
19990511110000000_78	Some of them will die of liver disease but the figure is hard to define.	die liver diseas figur hard defin
19990511110000000_79	The National Institute of Health has just awarded a contract for a wide ranging eight year study of the hepatitis C virus and answers to many questions will be forthcoming as the research moves along.	nation institut health ha award contract wide rang eight year studi hepat c viru answer mani question forthcom research move along
19990511110000000_80	But for now there will be various opinions on what causes hepatitis C and uncertainty may fuel more hysteria.	variou opinion caus hepat c uncertainti may fuel hysteria
19990511110000000_81	Paul Lomartire writes for the Palm Beach Post West Palm Beach Fla.	paul lomartir write palm beach post west palm beach fla
19990511110000000_82	Story Filed By Cox Newspapers For Use By Clients of the New York Times News Service.	stori file cox newspap use client new york time news servic
19990607200300000_1	DRUG REGIMEN CREDITED WITH BEATING AGGRESSIVE TUMOR.	drug regimen credit beat aggress tumor
19990607200300000_2	But in a scenario every parent fears 5 year old Jennifer LaChance s problem eventually proved to be a large aggressive tumor in her jaw.	scenario everi parent fear year old jennif la chanc problem eventu prove larg aggress tumor jaw
19990607200300000_3	Jennifer s tumor technically was not cancer yet it was so aggressive and resistant to standard treatment that it was almost as menacing.	jennif tumor technic wa cancer yet wa aggress resist standard treatment wa almost menac
19990607200300000_4	Laced with a dense web of blood vessels that fed its growth the tumor kept coming back within months after surgeons twice removed it.	lace dens web blood vessel fed grow th tumor kept come back within month surgeon twice remov
19990607200300000_5	At its biggest the tumor kept her from closing her mouth and her teeth were pushed out of place.	biggest tumor kept close mouth teeth push place
19990607200300000_6	Surgeons resorted to removing half her lower jaw in hopes of getting it all but still the tumor grew back.	surgeon resort remov half lower jaw hope get still tumor grew back
19990607200300000_7	That was a tough time for us said her mother of the period in 1994.	wa tough time us said mother period
19990607200300000_8	Radiation was one fallback treatment but doctors feared it would stunt growth in one side of Jennifer s face while the other side grew normally.	radiat wa one fallback treatment doctor fear would stunt grow th one side jennif face side grew normal
19990607200300000_9	Faced with this dilemma their oral surgeon Dr.	face thi dilemma oral surgeon dr
19990607200300000_10	Leonard Kaban of Massachusetts General Hospital consulted Dr.	leonard kaban massachusett gener hospit consult dr
19990607200300000_11	Judah Folkman head of the surgical research lab at Children s Hospital in Boston.	judah folkman head surgic research lab children hospit boston
19990607200300000_12	Folkman had pioneered the use of drugs that can treat tumors rich in blood vessels called hemangiomas in children by cutting off the private blood supply the tumors recruit from nearby tissues.	folkman pioneer use drug treat tumor rich blood vessel call hemangioma children cut privat blood suppli tumor recruit nearbi tissu
19990607200300000_13	In a paper being published Tuesday in the journal Pediatrics Folkman Kaban and colleagues describe how the tumor was finally beaten with a yearlong regimen of a drug interferon alfa 2a that knocked out the tumor s ability to recruit new blood vessels.	paper publish tuesday journal pediatr folkman kaban colleagu describ tumor wa final beaten yearlong regimen drug interferon alf knock tumor abil recruit new blood vessel
19990607200300000_14	Folkman has discussed the case to rapt audiences at medical meetings but had not previously identified Jennifer.	folkman ha discuss case rapt audienc medic meet previous identifi jennif
19990607200300000_15	What broke the treatment impasse was Folkman s suggestion that Jennifer s blood be tested for the presence of a protein called basic fibroblast growth factor (basic FGF).	broke treatment impass wa folkman suggest jennif blood test presenc protein call basic fibroblast grow th factor basic fgf
19990607200300000_16	He suspected that Jennifer s tumor might be secreting FGF a so called angiogenic factor that the tumor puts out as a signal for nearby tissues to sprout new vessels to feed it.	suspect jennif tumor might secret fgf call angiogen factor tumor put signal nearbi tissu sprout new vessel feed
19990607200300000_17	And Folkman knew recent research had shown that interferon alpha made by the body s immune system could shut down overproduction of FGF.	folkman knew recent research shown interferon alpha made bodi immun system could shut overproduct fgf
19990607200300000_18	Her blood contained many times the normal amount of FGF.	blood contain mani time normal amount fgf
19990607200300000_19	That was exciting because now we had a treatment that could potentially help her without having the drastic side effects of radiation therapy Kaban said Monday.	wa excit becaus treatment could potenti help without drastic side effect radiat therapi kaban said monday
19990607200300000_20	Folkman reasoned You could give interferon alpha at a low dose every day without causing the side effects it can trigger in large doses.	folkman reason could give interferon alpha low dose everi day without caus side effect trigger larg dose
19990607200300000_21	We started giving her small injections at night and by four weeks the tumor was gone he said.	start give small inject night four week tumor wa gone said
19990607200300000_22	Jennifer had few side effects except early in the treatment when she had hallucinations and saw gummy bears running around the house said her mother.	jennif side effect except earli treatment hallucin saw gum bear run around hous said mother
19990607200300000_23	The doctors were gratified to see that as the interferon treatment progressed and the tumor shrank Jennifer s blood levels of FGF fell.	doctor gratifi see interferon treatment progress tumor shrank jennif blood level fgf fell
19990607200300000_24	That was strong evidence that the interferon was shrinking the tumor by shutting off its FGF signals in search of new blood vessels.	wa strong evid interferon wa shrink tumor shut fgf signal search new blood vessel
19990607200300000_25	Twice during the year of treatment the doses had to be raised because the tumor was coming back but both times it worked.	twice dure year treatment dose rais becaus tumor wa come back time work
19990607200300000_26	The tumor called a giant cell tumor appears to be gone for good and her missing jawbone has regrown somewhat to the doctors surprise.	tumor call giant cell tumor appear gone good miss jawbon ha regrown doctor surpris
19990607200300000_27	Looking at her says her father Michael If you didn t know it you wouldn t think anything was wrong.	look say father michael know think anyth wa wrong
19990607200300000_28	It is believed to be the first time that a giant cell tumor of the jaw has been cured with a drug that inhibits angiogenesis the growth of blood vessels that allow a tumor to enlarge and spread.	believ first time giant cell tumor jaw ha cure drug inhibit angiogenesi grow th blood vessel allow tumor enlarg spread
19990607200300000_29	Since then the treatment has been used successfully in about six other cases says Folkman.	sinc treatment ha use success fulli six case say folkman
19990607200300000_30	The half of Jennifer s jaw that had been removed grew back during her year of therapy.	half jennif jaw remov grew back dure year therapi
19990607200300000_31	whether the interferon was responsible isn t clear said Kaban.	whether interferon wa respons clear said kaban
19990607200300000_32	She is still missing all her lower teeth on that side but Kaban said it isn t a major problem and that she can have implants put in when she s older.	still miss lower teeth side kaban said jor problem implant put older
19990607200300000_33	Angiogenesis inhibitors pioneered by Folkman and his colleagues at Children s Hospital are in the spotlight because they show enormous promise for treating cancer by starving it of its blood supply.	angiogenesi inhibitor pioneer folkman hi colleagu children hospit spotlight becaus show enorm promis treat cancer starv blood suppli
19990607200300000_34	Interferon is one of the weaker angiogenesis inhibitors Folkman says.	interferon one weaker angiogenesi inhibitor folkman say
19990607200300000_35	Yet it worked well in Jennifer s case by being given over a long period.	yet work well jennif case given long period
19990607200300000_36	That s how Folkman believes newer and stronger angiogenesis inhibitors like the promising drugs endostatin and angiostatin that have not yet been tested in people may be able to control cancer.	folkman believ newer stronger angiogenesi inhibitor like promis drug endostatin angiostatin yet test peopl may abl control cancer
19990701034400000_1	A tiny mail order pharmacy in Pennsylvania is preparing to do battle against drug giant Schering Plough Corp.	tini mail order pharmaci pennsylvania prepar battl drug giant schere plough corp
19990701034400000_2	for a stake in the burgeoning market for hepatitis C treatments.	stake burgeon market hepat c treatment
19990701034400000_3	Fisher s Specialized Pharmacy Services in Pittsburgh has announced plans to fill prescriptions nationwide for the anti viral drug ribavirin used by growing numbers of hepatitis C patients in combination with the drug interferon.	fisher special pharmaci servic pitt burgh ha announc plan fill prescript nation wide anti viral drug ribavirin use grow number hepat c patient combin drug interferon
19990701034400000_4	The hepatitis C virus or HCV is typically spread through contact with contaminated blood and now infects an estimated 4 million Americans although only about 1 million have been diagnosed.	hepat c viru hcv typic spread contact contamin blood infect estim million american although onli million diagnos
19990701034400000_5	Chronic carriers often go decades without symptoms but may eventually develop severe liver damage.	chronic carrier often go decad without symptom may eventu develop sever liver damag
19990701034400000_6	The ribavirin interferon combination generates a lasting response in fewer than half of those who try it often at the cost of serious side effects.	ribavirin interferon combin gener last respons fewer half tri often cost seriou side effect
19990701034400000_7	Still the combination is considered the best treatment now available for most patients.	still combin consid best treatment avail patient
19990701034400000_8	Schering reported worldwide sales of 719 million for the two drugs last year reflecting both a growing demand among HCV patients as well as some use for treating cancer and other conditions.	schere report worldwid sale million two drug last year reflect grow demand among hcv patient well use treat cancer condit
19990701034400000_9	The company claims more than 80 percent of the HCV drug market.	compani claim percent hcv drug market
19990701034400000_10	But along with that success the New Jersey based drugmaker has also generated complaints of high prices and overly aggressive marketing tactics.	along success new jersey base drugmak ha also gener complaint high price overli aggress market tactic
19990701034400000_11	In the United States Schering Plough has been the sole source of ribavirin sold only as part of a kit that also include s the company s proprietary brand of interferon called Intron A.	unit state schere plough ha sole sourc ribavirin sold onli part kit also includ compani proprietari brand interferon call intron
19990701034400000_12	Some patient advocates charge that Schering s bundling strategy has made it difficult for people to experiment with different drug combinations and dosages.	patient advoc charg schere bundl strategi ha made difficult peopl experi differ drug combin dosag
19990701034400000_13	It s anticompetitive said Brian Klein a San Francisco leader of a national patients group called the Hepatitis C Action and Advocacy Coalition.	anticompetit said brian klein san francisco leader nation patient group call hepat c action advocaci coalit
19990701034400000_14	The group issued nationwide e mail alerts this week announcing the new source of ribavirin complete with the Pittsburgh pharmacy s toll free phone number (888 347 3416) and Web site (www.	group issu nation wide e mail alert thi week announc new sourc ribavirin complet pitt burgh pharmaci toll free phone number web site www
19990701034400000_15	Schering s spokesman Robert Consalvo said the company is convinced that its package is the safest most convenient way to make the drugs available.	schere spokesman robert consalvo said compani convinc packag safest conveni way make drug avail
19990701034400000_16	Special compassionate use arrangements can be worked out for patients who need ribavirin alone he added.	special compassion use arrang work patient need ribavirin alon ad
19990701034400000_17	The HCV drug kit was specifically approved only as a combination product by the U.	hcv drug kit wa specif approv onli combin product u
19990701034400000_18	By contrast European authorities have banned such practices forcing Schering to seek approval to market each product individually.	contrast european author ban practic forc schere seek approv market product individu
19990701034400000_19	That application was approved by European regulators just last month.	applic wa approv european regul last month
19990701034400000_20	The Pittsburgh pharmacy said it holds all the necessary licenses to fill mail order prescriptions as a so called compounding pharmacy referring to the specialized practice of preparing individual drug orders.	pitt burgh pharmaci said hold necessari licens fill mail order prescript call compound pharmaci refer special practic prepar individu drug order
19990701034400000_21	Betty Stein one of three pharmacists at Fisher s would not disclose her supplier of ribavirin other than to say it is imported from abroad.	betti stein one three pharmacist fisher would disclos supplier ribavirin say import abroad
19990701034400000_22	She said the product has been tested and found to be pure.	said product ha test found pure
19990701034400000_23	The pharmacy plans to fill capsules as individual prescription orders are received starting after midnight July 8 when certain U.	pharmaci plan fill capsul individu prescript order receiv start midnight juli certain u
19990701034400000_24	The mail order pharmacy is offering the anti viral drug at 1.	mail order pharmaci offer anti viral drug
19990701034400000_25	That works out to about one fifth the cost of the same drug obtained in the Schering Plough combination kit.	work one fifth cost drug obtain schere plough combin kit
19990701034400000_26	Consalvo said the drugmaker has no plans to change its marketing practices or prices.	consalvo said drugmak ha plan chang market practic price
19990701034400000_27	He also said that patients need to be wary of the possibility that other sources of ribavirin may not meet the manufacturer s standards for purity and other chemical factors.	also said patient need wari possibl sourc ribavirin may meet manufactur standard puriti chemic factor
19990726224009000_1	PITTSBURGH (AP) A pharmacy that has had to turn away hepatitis C patients who couldn t pay 1 400 a month for the only treatment available has started selling the drugs itself at half the price.	pittsburgh ap pharmaci ha turn away hepat c patient pay month onli treatment avail ha start sell drug half price
19990726224009000_2	Fisher s Specialized Pharmacy Services a drug store in Pittsburgh began selling its version of the drugs this month.	fisher special pharmaci servic drug store pitt burgh began sell version drug thi month
19990726224009000_3	said Don Kerrish one of the three druggists who own the pharmacy.	said kerrish one three druggist pharmaci
19990726224009000_4	Hepatitis C is spread by blood and affects an estimated 3.	hepat c spread blood affect estim
19990726224009000_5	It can lead to chronic liver problems including cirrhosis and cancer.	lead chronic liver problem includ cirrhosi cancer
19990726224009000_6	Schering Plough s treatment known as Rebetron consists of Ribavirin which simply helps another drug interferon fight the virus.	schere plough treatment known rebetron consist ribavirin simpli help anoth drug interferon fight viru
19990726224009000_7	The company uses a type of interferon called Intron A the only type approved for use with Ribavirin for treating hepatitis C.	compani use type interferon call intron onli type approv use ribavirin treat hepat c
19990726224009000_8	Fisher s is selling Ribavirin for 225 a month and separately an interferon not made by Schering Plough for 420 a month.	fisher sell ribavirin month separ interferon made schere plough month
19990726224009000_9	The pharmacists said they have received about 10 calls a day from potential patients since they started the sales July 9.	pharmacist said receiv call day potenti patient sinc start sale juli
19990726224009000_10	For now the Food and Drug Administration is letting both sell their drugs.	food drug administr let sell drug
19990726224009000_11	Brian Klein an activist with the Hepatitis C Action and Advocacy Council said Schering Plough packages the drugs together just to make more money.	brian klein activist hepat c action advocaci council said schere plough packag drug togeth make money
19990726224009000_12	Doctors and patients need to have the access and flexibility to make the choices they deem appropriate not the drug company he said.	doctor patient need access flexibl make choic deem appropri drug compani said
19990726224009000_13	Schering Plough has asked the FDA to look into whether Fisher s is violating federal guidelines.	schere plough ha ask fda look whether fisher violat feder guidelin
19990726224009000_14	By promoting the drugs the pharmacy is moving toward manufacturing which is not allowed Schering Plough claims.	promot drug pharmaci move toward manufactur allow schere plough claim
19990726224009000_15	Kerrish said the pharmacy is meeting federal regulations and selling safe drugs.	kerrish said pharmaci meet feder regul sell safe drug
19990726224009000_16	Schering Plough says its treatment which earned 248 million in the 12 months ending May 1999 is the only one proven to work.	schere plough say treatment earn million month end may onli one proven work
19990726224009000_17	However the company says it is effective in only about 40 percent of the people who take it.	howev compani say effect onli percent peopl take
19990818222012000_1	7 million Americans carry the hepatitis C virus making it the most common blood borne infection in the United States according to a study in today s New England Journal of Medicine.	million american carri hepat c viru make common blood born infect unit state accord studi today new england journal medicin
19990818222012000_2	The study from the Centers for Disease Control and Prevention in Atlanta represents the first look at the prevalence of hepatitis C in the United States.	studi center diseas control prevent atlanta repres first look preval hepat c unit state
19990818222012000_3	This is what we consider a conservative estimate said Dr.	thi consid conserv estim said dr
19990818222012000_4	2 million other people who were once infected no longer have any signs of the virus Margolis said.	million peopl onc infect longer ani sign viru margoli said
19990818222012000_5	People who inject illegal drugs or engage in unprotected sex account for most people who carry hepatitis C but people who had blood transfusions before mid 1992 also are at risk.	peopl inject illeg drug engag unprotect sex account peopl carri hepat c peopl blood transfus befor mid also risk
19990818222012000_6	The disease and alcohol abuse rank as the leading causes of liver disease.	diseas al cohol abus rank lead caus liver diseas
19990818222012000_7	The infection can lead to cirrhosis and liver cancer and results in about 1 000 liver transplants annually in the United States.	infect lead cirrhosi liver cancer result liver transplant annual unit state
19990818222012000_8	The standard treatment is the drug interferon or a combination of interferon and ribavirin.	standard treatment drug interferon combin interferon ribavirin
19990818222012000_9	In some patients drugs can make all signs of the virus disappear but it s unclear how long the effect lasts.	patient drug make sign viru disappear unclear long effect last
19991102102300000_1	HOUSTON In a move that could save millions of dollars health care contractors for the Texas prison system are purchasing a drug used to treat hepatitis C from a small Pennsylvania pharmacy rather than from a pharmaceutical company whose marketing of the drug has been controversial.	houston move could save million dollar health care contractor texa prison system purchas drug use treat hepat c small pennsylvania pharmaci rather pharmaceut compani whose market drug ha controversi
19991102102300000_2	Starting this week the prison system s health maintenance organization will purchase the drug called Ribavirin from Fisher s Specialty Pharmacy Services in Pittsburgh said Dr.	start thi week prison system health mainten organ purchas drug call ribavirin fisher specialti pharmaci servic pitt burgh said dr
19991102102300000_3	Ribavirin is one of two components of a combination therapy approved last year by the Food and Drug Administration for treatment of hepatitis C.	ribavirin one two compon combin therapi approv last year food drug administr treatment hepat c
19991102102300000_4	Prison system health care officials decided in June to begin treating prisoners with the combination therapy after a study showed that 29 percent of the state s inmates or about 42 000 prisoners were infected with the potentially lethal liver virus.	prison system health care offici decid june begin treat prison combin therapi studi show percent state inmat prison infect potenti lethal liver viru
19991102102300000_5	Although many of those prisoners would not be candidates for treatment for various reasons officials have expressed concern that the high costs of the two drugs could have a serious impact on the prison health care budget.	although mani prison would candid treatment variou reason offici express concern high cost two drug could seriou impact prison health care budget
19991102102300000_6	Until recently Ribavirin was available for treatment of hepatitis C only as part of a kit marketed by Schering Plough Corp.	recent ribavirin wa avail treatment hepat c onli part kit market schere plough corp
19991102102300000_7	The other drug in the kit is Schering Plough s brand of alpha interferon.	drug kit schere plough brand alpha interferon
19991102102300000_8	For a standard one year course of treatment the retail cost of the two drugs is almost 18 000 per patient although Calhoun said the prison system was purchasing Rebetron for about 14 700.	standard one year cours treatment retail cost two drug almost per patient although calhoun said prison system wa purchas rebetron
19991102102300000_9	By obtaining the Ribavirin from Fisher s and the interferon from another supplier the prison system will reduce the cost of the combination therapy to about 5 000 per patient Calhoun said.	obtain ribavirin fisher interferon anoth supplier prison system reduc cost combin therapi per patient calhoun said
19991102102300000_10	That means we can treat more than twice as many patients for the same cost he said.	mean treat twice mani patient cost said
19991102102300000_11	Some doctors and patient groups have criticized Schering Plough for refusing to unbundle the two drugs marketed as a product called Rebetron so that patients could use Ribavirin with another brand of interferon.	doctor patient group critic schere plough refus unbundl two drug market product call rebetron patient could use ribavirin anoth brand interferon
19991102102300000_12	Schering Plough responded that the drug had been tested for this purpose only with its brand of interferon.	schere plough respond drug test thi purpos onli brand interferon
19991102102300000_13	Then in July Fisher s began compounding Ribavirin obtaining it from an overseas supplier and packing it into capsules then selling it to patients based on a doctor s prescription.	juli fisher began compound ribavirin obtain oversea supplier pack capsul sell patient base doctor prescript
19991102102300000_14	The pharmacy is charging 225 for a month s supply compared to 1 040 per month when the drug is purchased as part of the Schering Plough kit.	pharmaci charg month suppli compar per month drug purchas part schere plough kit
19991102102300000_15	Calhoun said only about 20 Texas prison inmates are receiving combination therapy but that the lower costs will make it possible to provide the treatment to many more.	calhoun said onli texa prison inmat receiv combin therapi lower cost make possibl provid treatment mani
19991102102300000_16	Bob Consalvo a spokesman for Schering Plough said the compounded Ribavirin that Fisher s is selling has not been subjected to the rigorous tests necessary to demonstrate that it is safe and effective in combination with interferon.	bob consalvo spokesman schere plough said compound ribavirin fisher sell ha subject rigor test necessari demonstr safe effect combin interferon
19991102102300000_17	An FDA spokeswoman said the agency could not comment on its response to Schering Plough s complaint.	fda spoke woman said agenc could comment respons schere plough complaint
19991102102300000_18	Calhoun said liver specialists at the University of Texas Medical Branch in Galveston one of the partners in the prison system s managed health care contract said tests have established that the drug supplied by Fisher s is identical to Schering Plough s version of Ribavirin.	calhoun said liver specialist univers texa medic branch galveston one partner prison system manag health care contract said test establish drug suppli fisher ident schere plough version ribavirin
19991102102300000_19	Don Kerrish a co owner of Fisher s said the pharmacy began looking for alternative ways to supply patients with Ribavirin after realizing that many patients including some with health insurance were unable to afford the Rebetron kit.	kerrish co owner fisher said pharmaci began look altern way suppli patient ribavirin realiz mani patient includ health insur unabl afford rebetron kit
19991102102300000_20	After the patent for Ribavirin expired recently he said the pharmacy s lawyers did some research and concluded that compounding the drug would be legal.	patent ribavirin expir recent said pharmaci lawyer research conclud compound drug would legal
19991102102300000_21	Kerrish also said he was contacted recently by an attorney in the Texas attorney general s office who told him that the office was looking at investigating Schering Plough for possible violations of anti trust laws.	kerrish also said wa contact recent attorney texa attorney gener offic told offic wa look investig schere plough possibl violat anti trust law
19991102102300000_22	Kerrish said the attorney asked him questions about the drugs used to treat hepatitis C.	kerrish said attorney ask question drug use treat hepat c
19991102102300000_23	) Star Ledger quoted an unnamed spokeswoman for the Texas attorney general s office as saying that an investigation of Schering Plough was in the initial stages.	star ledger quot unnam spoke woman texa attorney gener offic say investig schere plough wa initi stage
19991102102300000_24	Ted Delisi a spokesman for the attorney general s office said that the office s policy is never to confirm or deny investigations.	ted delisi spokesman attorney gener offic said offic polici never confirm deni investig
20000522201300000_1	DEVELOPER OF CANCER DRUG PLEASED WITH HUMAN TRIALS.	develop cancer drug pleas human trial
20000522201300000_2	NEW ORLEANS Responding to reports that the highly touted anticancer drug endostatin has failed to impress in its first human tests Dr.	new orlean respond report highli tout anticanc drug endostatin ha fail impress first human test dr
20000522201300000_3	Judah Folkman of Children Hospital in Boston told thousands of cancer specialists Monday that he was very pleased with the drug s early trials in Boston and hinted there will be more good news ahead.	judah folkman children hospit boston told thou cancer specialist monday wa veri pleas drug earli trial boston hint good news ahead
20000522201300000_4	Addressing a standing room only crowd at the American Society of Clinical Oncology meeting Folkman who developed endostatin in Boston labs urged specialists not to be discouraged if the drugs don t work right away.	address stand room onli crowd american societi clinic oncolog meet folkman develop endostatin boston lab urg specialist discourag drug work right away
20000522201300000_5	Folkman was making the first public comments to cancer specialists about the drug s effectiveness since a National Cancer Institute official was quoted in the Globe earlier this month saying no dramatic benefits have been seen in endostatin trials going on now in Boston and two other cities.	folkman wa make first public comment cancer specialist drug effect sinc nation cancer institut offici wa quot globe earlier thi month say dramat benefit seen endostatin trial go boston two citi
20000522201300000_6	That report sent the stock in Maryland based Entremed Inc.	report sent stock maryland base entrem inc
20000522201300000_7	Investors have been closely following the development of endostatin and Folkman s progress ever since a scientist predicted in 1998 that Folkman would cure cancer within two years.	investor close follow develop endostatin folkman progress ever sinc scientist predict folkman would cure cancer within two year
20000522201300000_8	That hasn t happened but the enthusiasm of some investors and scientists has barely been dented as they await results of the endostatin trials.	happen enthusiasm investor scientist ha bare dent await result endostatin trial
20000522201300000_9	Because patients began receiving endostatin in the Boston study in October two months ahead of the other centers Folkman seemed to hint Monday that the drug s effectiveness improves over time.	becaus patient began receiv endostatin boston studi octob two month ahead center folkman seem hint monday drug effect improv time
20000522201300000_10	Folkman however does not directly oversee the trials from which no official data has been reported and cannot speak publicly about them.	folkman howev doe directli overse trial offici data ha report cannot speak publicli
20000522201300000_11	However he said Monday We are very pleased with the results at the Boston hospital.	howev said monday veri pleas result boston hospit
20000522201300000_12	He also disclosed the results of other cases in which so called angiogenesis inhibitors of which endostatin is one have proved to be powerful cancer fighters.	also disclos result case call angiogenesi inhibitor endostatin one prove power cancer fighter
20000522201300000_13	Unlike standard cancer drugs that attack tumors directly angiogenesis inhibitors cut off the tumor s blood supply and slowly strangles them or at least halts their growth.	unlik standard cancer drug attack tumor directli angiogenesi inhibitor cut tumor blood suppli slowli strangl least halt grow th
20000522201300000_14	Folkman said Monday that in about 80 cancer patients mostly children the drugs destroyed growths that would have killed them.	folkman said monday cancer patient mostli children drug destroy growth would kill
20000522201300000_15	If we d given up in the first month or two they wouldn t be around he said.	given first month two around said
20000522201300000_16	One of the most dramatic cases was that of a Vermont teenager who in 1998 had a volleyball sized pelvic tumor that resisted all therapies.	one dramat case wa vermont teenag volley ball size pelvic tumor resist therapi
20000522201300000_17	She had been sent home to die Folkman said but after months of treatment with an angiogenesis inhibitor the growth began to shrink and today she is free of cancer.	sent home die folkman said month treatment angiogenesi inhibitor grow th began shrink today free cancer
20000522201300000_18	The patient Tonya Kalesnik of Colchester may be alive only because her doctor went to a Folkman lecture at a time when specialists had tried every treatment they knew but failed to halt her tumor s growth.	patient tonya kalesnik colchest may aliv onli becaus doctor went folkman lectur time specialist tri everi treatment knew fail halt tumor grow th
20000522201300000_19	In a telephone interview Monday Kalesnik said she was in constant and excruciating pain incontinent and her legs were increasingly numb as the tumor grew.	telephon interview monday kalesnik said wa constant excruci pain incontin leg increasingli numb tumor grew
20000522201300000_20	Kalesnik s doctor got in touch with Folkman and eventually prescribed interferon alpha an infection fighting substance that is a weak angiogenesis inhibitor.	kalesnik doctor got touch folkman eventu prescrib interferon alpha infect fight substanc weak angiogenesi inhibitor
20000522201300000_21	It is also effective in blocking a substance some tumors secrete which signal the body to grow more blood vessels.	also effect block substanc tumor secret signal bodi grow blood vessel
20000522201300000_22	Kalesnik s tumor called a giant cell tumor was of a type that doesn t spread through the body but kills through sheer size.	kalesnik tumor call giant cell tumor wa type spread bodi kill sheer size
20000522201300000_23	Folkman prescribed nightly injections of interferon alpha but it wasn t until three months had passed that doctors observed that the tumor seemed to have stabilized.	folkman prescrib nightli inject interferon alpha three month pass doctor observ tumor seem stabil
20000522201300000_24	It was the first time it had done something other than grow said Kalesnik who is taking a break from her freshman year at the University of Vermont.	wa first time done someth grow said kalesnik take break freshman year univers vermont
20000522201300000_25	Over the next 18 months the tumor shrank by about 80 percent and Folkman believes she may be able to stop taking the drug within a few months.	next month tumor shrank percent folkman believ may abl stop take drug within month
20000522201300000_26	Because the anti angiogenesis drugs work slowly in small doses over along periods of time Folkman said the standard way of conducting initial clinical trials may not be appropriate.	becaus anti angiogenesi drug work slowli small dose along period time folkman said standard way conduct initi clinic trial may appropri
20000522201300000_27	In other words angiogenesis inhibitors might be thought not to be effective against tumors if they grow despite treatment but treating for longer periods might eventually rein in the cancer he said.	word angiogenesi inhibitor might thought effect tumor grow despit treatment treat longer period might eventu rein cancer said
20000522201300000_28	Interferon has also saved many children with life threatening growths called hemangiomas.	interferon ha also save mani children life threaten growth call hemangioma
20000522201300000_29	Folkman showed slides of infants with enormous disfiguring tumors that are made of thousands of blood vessels.	folkman show slide infant enorm disfigur tumor made thou blood vessel
20000522201300000_30	These life threatening growths which also produce substances that tell the body to create more blood vessels also responded well to interferon treatment he said.	life threaten growth also produc substanc tell bodi creat blood vessel also respond well interferon treatment said
20000522201300000_31	Folkman said about 40 reports have been disclosed on tests of angiogenesis inhibitors in cancer.	folkman said report disclos test angiogenesi inhibitor cancer
20000522201300000_32	Most have been inconclusive but some show promise that will be explored in wider testing.	inconclus show promis explor wider test
20000926073800000_1	One of the drugs used to control multiple sclerosis also sharply slows the rate at which people develop the crippling nerve disease according to researchers.	one drug use control multipl sclerosi also sharpli slow rate peopl develop crippl nerv diseas accord research
20000926073800000_2	The finding from an international study halted early because the results were so strong could help thousands of patients who currently don t get treatment until they have substantial brain or nerve damage.	find intern studi halt earli becaus result strong could help thou patient current get treatment substanti brain nerv damag
20000926073800000_3	It s a very important finding because it really shows if one starts treatment early on one can change the fate of a patient delaying or even preventing the onset of the disease said Dr.	veri import find becaus realli show one start treatment earli one chang fate patient delay even prevent onset diseas said dr
20000926073800000_4	Thomas Leist director of the Comprehensive Multiple Sclerosis Center at Thomas Jefferson University in Philadelphia.	thoma leist director comprehens multipl sclerosi center thoma jefferson univers philadelphia
20000926073800000_5	It opens up a new perspective about treatment of multiple sclerosis said Leist who was not involved in the study which will be published in Thursday s New England Journal of Medicine.	open new perspect treatment multipl sclerosi said leist wa involv studi publish thursday new england journal medicin
20000926073800000_6	Until now people who suffer inflammation of nerves in the eye spinal cord or lower brain indications that MS might be developing have not been diagnosed with the autoimmune disorder let alone treated.	peopl suffer inflamm nerv eye spinal cord lower brain indic ms might develop diagnos autoimmun disord let alon treat
20000926073800000_7	The diagnosis only follows a second flare up elsewhere in the central nervous system.	diagnosi onli follow second flare el se central nervou system
20000926073800000_8	However researchers at the State University of New York School of Medicine at Buffalo and about 50 other U.	howev research state univers new york school medicin buffalo u
20000926073800000_9	and Canadian sites concluded that giving patients a drug called interferon beta 1a within weeks of the first nerve inflammation cut the likelihood of developing MS symptoms within three years by 44 percent.	canadian site conclud give patient drug call interferon beta within week first nerv inflamm cut likelihood develop ms symptom within three year percent
20000926073800000_10	Only one third of patients who gave themselves weekly thigh injections of the drug developed MS within three years compared with half the patients who injected a harmless substance.	onli one third patient gave themselv weekli thigh inject drug develop ms within three year compar half patient inject harmless substanc
20000926073800000_11	Stephen Reingold vice president for research programs at the National Multiple Sclerosis Society said the findings will push doctors to promptly order magnetic resonance imaging in patients with an initial nerve flare up.	stephen reingold vice presid research program nation multipl sclerosi societi said find push doctor promptli order magnet reson imag patient initi nerv flare
20000926073800000_12	If brain lesions scarring that indicates past inflammation are spotted during the MRI Reingold said it should encourage treatment with this interferon.	brain lesion scar indic past inflamm spot dure mri reingold said encourag treatment thi interferon
20000926073800000_13	In multiple sclerosis the body s immune system goes awry and attacks the nerves and brain slowly stripping away the protective insulation coating nerve fibers.	multipl sclerosi bodi immun system goe awri attack nerv brain slowli strip away protect insul coat nerv fiber
20000926073800000_14	That damage builds up over years to cause muscle weakness or paralysis fatigue dim or blurred vision memory loss and other problems with thinking.	damag build year caus muscl weak paralysi fatigu dim blur vision memori loss problem think
20000926073800000_15	Some people merely suffer mild weakness for decades while others steadily worsen from repeated attacks.	peopl mere suffer mild weak decad steadili worsen repeat attack
20000926073800000_16	Along with giving patients steroids to reduce inflammation during each attack doctors have offered three drugs that reduce the frequency and severity of attacks and slow the progression of the disease.	along give patient steroid reduc inflamm dure attack doctor offer three drug reduc frequenc sever attack slow progress diseas
20000926073800000_17	One of them interferon beta 1a known by the brand name Avonex is a genetically engineered replica of a naturally occurring human protein said the lead researcher Dr.	one interferon beta known brand name avonex genet engin replica natur occur human protein said lead research dr
20000926073800000_18	Lawrence Jacobs professor of neurology at SUNY Buffalo and head of neurology at Buffalo General Hospital.	lawrenc jacob professor neurolog suni buffalo head neurolog buffalo gener hospit
20000926073800000_19	It works by reducing inflammation and quieting down the overactive immune system.	work reduc inflamm quiet overact immun system
20000926073800000_20	Along with delaying the onset of MS Avonex cut the number of new or actively inflamed lesions detected by MRIs by more than half compared with patients in the comparison group.	along delay onset ms avonex cut number new activ inflam lesion detect mri half compar patient comparison group
20000926073800000_21	It also cut the total volume of such lesions in the nervous system by 91 percent over the comparison patients Jacobs said.	also cut total volum lesion nervou system percent comparison patient jacob said
20000926073800000_22	European researchers recently came up with a similar finding on Avonex s effects when it is used early.	european research recent came similar find avonex effect use earli
20000926073800000_23	The 383 people in the latest study had suffered an initial nerve flare up and had at least two brain lesions detected by an MRI Jacobs said.	peopl latest studi suffer initi nerv flare least two brain lesion detect mri jacob said
20000926073800000_24	Until MRIs recently enabled doctors to see inside live brains they would not begin treatment for MS until the second nerve flare up confirmed the diagnosis.	mri recent enabl doctor see insid live brain would begin treatment ms second nerv flare confirm diagnosi
20000926073800000_25	in about half the patients something else such as infection caused the initial inflammation.	half patient someth els infect caus initi inflamm
20000926073800000_26	In the meantime half of them have lesions in the brain that are smoldering and doing further damage Jacobs said.	meantim half lesion brain smolder damag jacob said
20000926073800000_27	About 350 000 Americans have multiple sclerosis and one fifth of them are in this group with silent brain damage who could be helped by aggressive treatment.	american multipl sclerosi one fifth thi group silent brain damag could help aggress treatment
20000926073800000_28	Leist said its price tag of about 10 000 annually could limit use.	leist said price tag annual could limit use
20000926073800000_29	He also said that patients need to be followed for longer than three years to determine how long they need the interferon treatment and that other MS drugs should be studied to determine if there are similar benefits when given earlier.	also said patient need follow longer three year determin long need interferon treatment ms drug studi determin similar benefit given earlier
